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ABSTRACT 
 
 
Cortical bone is a dynamic tissue which undergoes adaptive and pathological changes 
throughout life. An improved understanding of the spatio-temporal process of remodeling holds 
great promise for improving our understanding of bone development, maintenance and 
senescence. The use of micro-computed tomography (µCT) on living animals is relatively new 
and allows the three dimensional quantification of change in trabecular bone microarchitecture 
over time. The use of in vivo µCT is limited by the radiation dose created by the x-ray beam, 
with commercially available in vivo systems generally operating in the 10-20 um resolution 
range and delivering an absorbed dose between 0.5-1 Gy. Because dose scales to the power of 
four with resolution, in vivo imaging of the cortical canal network, which requires a higher 
resolution, has not been achieved. I hypothesized that using synchrotron propagation phase 
contrast µCT, cortical porosity could be imaged in vivo in rats at a dose on the same level as 
those used currently for trabecular bone analysis. Using the BMIT-BM beamline, I determined 
the optimal propagation distance and used ion chamber and lithium fluoride crystal 
thermoluminescent dosimetry to measure the absorbed dose of my in vivo protocol as well as 
several ex vivo protocols using synchrotron phase contrast µCT at 5 µm, 10 µm, and 11.8 µm 
and conventional desktop in vivo protocols using commercial µCT systems. Using synchrotron 
propagation phase contrast µCT, I scanned the forelimb of two adult Sprague-Dawley rats and 
measured an absorbed dose of 2.53 Gy. Using two commercial µCT system, I measured doses 
between 1.2-3.6 Gy for protocols at 18µm that are in common use. This thesis represents the first 
in vivo imaging of rat cortical porosity and demonstrates that an 11.8 µm resolution is enough to 
visualize cortical porosity in rats, with a dose within the scope of those used for imaging 
trabecular bone in vivo.  
iii  
ACKNOWLEDGEMENTS 
 
I am grateful for the contributions and efforts of many colleagues and friends that have 
made this thesis possible. To begin, I must thank my supervisor Dr. David Cooper, for taking a 
chance on me. His expertise, knowledge, and patience has made my graduate experience 
profound and worthwhile. The rest of my graduate committee, Dr. Julia Boughner and Dr. Dean 
Chapman, deserve many thanks as well, for critical but kind words and assistance freely given. 
I have had the great fortune to encounter many great academics though the start of my 
academic career, and they have been inspirations and goals. I’ve learned more from you than you 
know. In no particular order, Dr. Susan Pfeiffer, Dr. Emmanuel Istrate, Dr. David Begun, Dr. 
Bonnie Glencross, Dr. Gerry De Iuliis, Dr. Ernie Walker, Dr. Angela Lieverse, and Dr. Gregg 
Adams. 
To everyone who contributed to the development of this thesis, thank you. Dr. George 
Belev, your support at BMIT has been invaluable. Without you and the rest of the BMIT team, 
Dr. Tomasz Wysokinski, Dr. Adam Webb, and Dr. Ning Zhu, I’d be lost in a sea of murk and 
radiation. To Dr. Mike Doschak and Imran Khan in Alberta, your assistance was indispensable.  
 To my friends in the lab, the department, and at the University, thank you. Yasmin 
Carter, Kim Harrison, Cheryl Hennig, Treena Swanston, Carter Britz, Mylyne Tham, Megan 
Clarke, Muhammad Raj, without you all I’d surely have gone mad.  
 To my family, without your support, I would not have made it here. Mom and Dad, thank 
you for believing in me, and supporting me through all my ups and downs, and encouraging me 
in all my strange interests. To my brother, thanks for putting up with me.  
iv  
 To my friends, in Saskatoon and in Toronto, and elsewhere. Thank you for being there. 
To Averi and Millie, you made Saskatchewan easier. To KAKC, VL, SR, BO, HK, MEC, SLD, 
JN, SC, AA, JS, you make my life better by being in it.  
 To everyone mentioned and not mentioned, there aren’t enough terms in the thesaurus to 
properly thank you. 
 To my rats, thank you for your sacrifice.
v  
  
 
 
 
 
 
 
 
 
 
 
 
For my parents, if you think this is long, just wait till you see the next one 
vi  
TABLE OF CONTENTS 
 
PERMISSION TO USE ................................................................................................................. i!
ABSTRACT ................................................................................................................................... ii!
ACKNOWLEDGEMENTS ........................................................................................................ iii!
DEDICATION .............................................................................................................................. v!
TABLE OF CONTENTS ............................................................................................................ vi!
LIST OF TABLES ..................................................................................................................... viii!
LIST OF FIGURES ..................................................................................................................... ix!
LIST OF ABREVIATIONS ....................................................................................................... xii!
CHAPTER ONE: INTRODUCTION ......................................................................................... 1!
1.1 Introduction ....................................................................................................................................... 1!
1.2 Bone microstructure ......................................................................................................................... 1!
1.3 Bone growth and repair ................................................................................................................... 3!
1.3.1 Growth ......................................................................................................................................... 3!
1.3.2 Modeling ...................................................................................................................................... 3!
1.3.3 Remodelling ................................................................................................................................ 3!
1.4 Cortical bone imaging ....................................................................................................................... 6!
1.5 Organization of the thesis ................................................................................................................. 8!
CHAPTER 2: THE STATE OF IN VIVO MICRO-COMPUTED TOMOGRAPHY 
IMAGING OF BONE ................................................................................................................... 9!
2.1 Introduction to bone microstructure .............................................................................................. 9!
2.1.1 Trabecular bone ........................................................................................................................... 9!
2.1.2 Cortical bone ............................................................................................................................. 13!
2.2. Micro computed tomography ....................................................................................................... 16!
2.2.1 Synchrotron µCT ....................................................................................................................... 16!
2.2.2 Desktop µCT ............................................................................................................................. 17!
2.2.3 Dose ........................................................................................................................................... 17!
2.2.4 Dosimetry .................................................................................................................................. 19!
2.2.5 Scan parameters impacting dose ............................................................................................... 21!
2.3 Small animal µCT in vivo ............................................................................................................... 23!
2.3.1 Synchrotron in vivo µCT ........................................................................................................... 25!
2.3.2 Desktop in vivo µCT ................................................................................................................. 27!
2.3.3 Effects of radiation dose on bone .............................................................................................. 29!
2.4 Conclusion ....................................................................................................................................... 34!
CHAPTER 3: PHASE CONTRAST SYNCHROTRON µCT ................................................ 35!
3.1 Introduction ..................................................................................................................................... 35!
3.2 Phase contrast .................................................................................................................................. 36!
3.3 Materials and methods ................................................................................................................... 43!
3.3.1 Animals ...................................................................................................................................... 43!
3.3.2 Synchrotron ex vivo µCT .......................................................................................................... 43!
3.3.3 Ex vivo phase contrast setup and optimization ......................................................................... 45!
3.3.5 Synchrotron in vivo µCT ........................................................................................................... 45!
vii  
3.3.4 Desktop µCT ............................................................................................................................. 47!
3.3.6 Software ..................................................................................................................................... 49!
3.3.7 Dosimetry .................................................................................................................................. 49!
3.4 Results .............................................................................................................................................. 50!
3.4.1 Resolution .................................................................................................................................. 50!
3.4.2 Impact of number of projections ............................................................................................... 51!
3.4.2 Propagation distance .................................................................................................................. 52!
3.4.3 Energy differences ..................................................................................................................... 53!
3.4.4 dosimetry ................................................................................................................................... 54!
3.4.5 in vivo SR µCT .......................................................................................................................... 55!
3.4.6 Comparison with desktop µCT .................................................................................................. 57!
3.5 Discussion ........................................................................................................................................ 60!
3.6 Conclusions ...................................................................................................................................... 64!
CHAPTER FOUR: CONCLUSION ......................................................................................... 66!
4.1 Overview .......................................................................................................................................... 66!
4.2 Future Directions ............................................................................................................................ 67!
4.3 Conclusion ....................................................................................................................................... 70!
REFERENCES ............................................................................................................................ 71!
 
 
viii  
LIST OF TABLES 
Table 2.1: Definition and description of 3D trabecular bone quantification parameters. ............ 11!
Table 2.2: Definition and description of 3D cortical bone gross geometrical and microstructural 
quantification parameters. ..................................................................................................... 15!
Table 2.3: Synchrotron protocols and their major features .......................................................... 32!
Table 2.4: Desktop µCT protocols and their major features ........................................................ 33!
Table 3.1: Synchrotron µCT imaging protocols used .................................................................. 46!
Table 3.2: Desktop µCT imaging protocols ................................................................................. 49!
Table 3.3: Measured doses for the different protocols ................................................................. 55!
 
ix  
LIST OF FIGURES 
Figure 1.1: Cortical bone. On the left of (A), a segment of a cross-section of human metacarpal 
cortical bone, surround the marrow cavity on the right of (A). In (B), a 3D volume render of 
a µCT cross-section of the same bone. In (C), a render of a segment of the neurovascular 
canal network. ......................................................................................................................... 2!
Figure 1.2: Trabecular bone. A 3D volume render of trabecular bone from the proximal radius 
of a rat ..................................................................................................................................... 2!
Figure 1.3: The basic structure of a BMU, with the osteoclast cutting cone shown at ‘A’, the 
resorption space shown at ‘B’, the osteoblast closing cone at ‘C’, and the resulting lamellar 
bone surrounding a Haversian canal at ‘D’. ............................................................................ 4!
Figure 2.1: Illustration of the MIL method of DA calculation. The mean intercept length is 
found by passing a line through a 3D volume containing the region of interest, counting the 
number of intersections this line makes with part of the tissue (in this case bone) in the 
region of interest, and dividing this number by the length of the line. Differences in the MIL 
across different angles reflect the anisotropy in the bone. As seen in ‘A’, lines passing 
through the sample intercept the bone a different number of times depending on their 
orientation with respect to the anisotropy of the tissue. In 3D, many such lines are passed 
through the tissue (‘B’) to obtain MILs for a large number of angles to fully quantify the 
anisotropy over the whole volume. Next each line is drawn passing through the origin (‘C’), 
and the resulting polar plot is fitted to a 3D ellipsoid with three main axes. The ellipsoid can 
be described as a tensor (3D matrix) with eigenvectors describing the strength of the 
anisotropy in the three major directions. From this tensor the DA can be calculated, by 
subtracting the division the maximum eigenvalue by the minimum eigenvalue from 1. The 
DA can then range from 0 to 1, where 0 is total isotropy and 1 is total anisotropy. Figure 
adapted from the CT-analyser manual (Bruker 2012). ......................................................... 12!
Figure 2.2: The energy absorption coefficients for soft tissue (ICRU4 NIST standard) and solid 
bone (NIST) in cm2/g plotted against energy, showing the decrease in energy absorption, 
and therefore absorbed dose, with higher x-ray energy. (Data from NIST, 
http://www.nist.gov/) ............................................................................................................ 23!
Figure 3.1: Phase contrast imaging setups. In A, the setup for propagation phase contrast is 
shown, with the increased sample-detector distance. In B, the setup for DEI is shown, with 
the analyzer crystal. In C, the setup for grating based phase contrast is shown, with the 
source grating G0, the phase grating G1, and the analyzer grating G2. ............................... 39!
Figure 3.2: Changes in the x-ray waveform through the use of propagation phase contrast. ...... 40!
Figure 3.3: The edge-enhancement effect can be seen in the graph on the right, where the bone 
tissue is on the left and the background is on the right. The phase peak has gray levels 
higher than the bone and lower than the background. The area in the graph is shown as the 
yellow line in the synchrotron µCT slice on the left. ............................................................ 41!
Figure 3.4: The x-ray source brightness for the BMIT bending magnet beam line, from 0 to 100 
keV. ....................................................................................................................................... 44!
x  
Figure 3.5: Rats positioned in the custom stage built at BMIT. On the left, a variant with the arm 
positioned in a tube in the beam. On the right, a variant with the arm held in a tube by a 
bridge. ................................................................................................................................... 46!
Figure 3.6: The difference between resolutions with 5 µm and 10 µm voxels using the C4742-
98-ERG camera. The phase propagation distance for the 5 µm image is 0.3 m and for the 10 
µm image is 0.6 m. ................................................................................................................ 51!
Figure 3.7: The impact of the number of projections on image quality can be seen, with a scan of 
360 projections on the left compared to a scan of 750 projections on the right. These scans 
were performed with the C4742-98-ERG camera at 10 µm, and all other parameters were 
kept equal. Slice matches are not exact. ............................................................................... 52!
Figure 3.8: The optimal phase distance for the C4742-98-ERG camera at 10 µm was found to be 
0.6 m. Selected propagation distances of 0.1 m, 0.6 m, and 1.0 m are shown for comparison.
............................................................................................................................................... 52!
Figure 3.9: The optimal phase distance for the C4742-98-ERG camera at 5 µm was found to be 
0.3 m. Selected propagation distances of 0.1 m, 0.6 m, and 0.6 m are shown for comparison. 
Slice matches are not exact. .................................................................................................. 53!
Figure 3.10: The optimal phase distance for the C4742-56-12HR camera was found to be 0.9 m. 
Selected propagation distances of 0.25 m, and 0.9 m are shown for comparison. Slice 
matches are not exact. ........................................................................................................... 53!
Figure 3.11: Differences in image quality using different x-ray energy in the tibia imaged using 
the C4742-98-ERG camera at 10 µm using a propagation distance of 0.6 m. Slice matches 
are not exact. ......................................................................................................................... 54!
Figure 3.12: Single slice from the in vivo synchrotron µCT showing cortical porosity measured 
using the C4742-56-12HR camera at 11.8 µm with a 2.53 Gy dose. ................................... 56!
Figure 3.13: Longitudinal slice parallel to the long axis of the forelimb shows canals within the 
cortical bone, resliced in ImageJ from the in vivo scan using the C4742-56-12HR camera at 
11.8 µm. ................................................................................................................................ 56!
Figure 3.14: Volume render of the cortical porosity in the forelimb µCT scan .......................... 57!
Figure 3:15: Slice reconstructed from the in vivo desktop SkyScan 1076 at 35 µm. Matching 
slice to the Synchrotron in vivo, any deviation is from positioning differences during the 
scans. Dose was not measured but is presumed to be lower than other scans. ..................... 58!
Figure 3:16: Slice reconstructed from the in vivo desktop SkyScan 1176 at 18 µm with a 1.2-1.5 
Gy dose. Matching slice to the Synchrotron in vivo, any deviation is from positioning 
differences during the scans. ................................................................................................. 58!
Figure 3:17: Slice reconstructed from the in vivo desktop SkyScan 1176 at 9 µm with an 11.7-
18.2 Gy dose. Matching slice to the Synchrotron in vivo, any deviation is from positioning 
differences during the scans. ................................................................................................. 59!
xi  
Figure 3.18: Slice reconstructed from the ex vivo desktop SkyScan 1172 at 6.5 µm. Matching 
slice to the Synchrotron in vivo, any deviation is from positioning differences during the 
scans. Dose was not measured but is presumed to be higher than other scans. .................... 59!
Figure 3.19: Brightness of the BMIT insertion device beamline compared to the BMIT bending 
magnet beamline. .................................................................................................................. 63!
 
xii  
LIST OF ABREVIATIONS 
 
° = degrees  
2D = two dimensional 
3D = three dimensional 
BMU = basic multicellular unit 
BMIT = BioMedical Imaging and Therapy  
BM = bending magnet 
CT = computed tomography 
DEI = diffraction enhanced imaging 
Gy = gray 
ID = insertion device 
keV = kiloelectronvolt 
kV = kilovolt 
mA = milliampere 
mGy = milligray 
mm = millimeter 
OSL = optically stimulated luminescence 
OVX = ovariectomized 
ROI = region of interest 
SR = synchrotron radiation 
TLD = thermoluminescent dosimeter 
vs = versus 
µA = microampere 
µCT = micro-computed tomography  
µm = micron 
 
1  
CHAPTER ONE: INTRODUCTION  
 
 
1.1 Introduction 
 Bone is a complex, dynamic tissue found in most living vertebrates, constantly adapting 
in response to internal and external stimuli. The only current living vertebrates without bone are 
the ‘cartilaginous fishes’, modern chondrichthyans such as sharks, rays, and skates, and even 
these animals are likely to have evolved from ancestral vertebrates containing bone (Eames et al. 
2007). Bone forms a rigid endoskeleton for an animal and provides many important functions in 
the body including red and white blood cell production in the marrow, and storage for minerals, 
heavy metals, and alkaline salts (Currey 2002). Approximately 65% of the dry weight of a bone 
is made up of a calcium-phosphate mineral, hydroxyapatite, which provides the majority of a 
bone’s compressive strength. The remaining 35% is organic, and mostly composed of collagen 
fibers along with a small percentage of other proteins (Pearson and Lieberman 2004), which is 
responsible for the bones tensile strength.  
1.2 Bone microstructure 
Bone has two main tissue types: cortical bone and trabecular bone. The first, illustrated in 
figure 1, is an outer, dense shell of bone with a perforating network of neurovascular canals, 
which surrounds the marrow cavity and in long bones is concentrated mainly in the diaphysis. 
The second, illustrated in figure 2, is trabecular bone, an inner load bearing compartment 
forming a mesh-like network of struts and plates, which in long bones is found mainly in the 
epiphyses (Currey 2002). These two bone tissues play different roles, complementing each other 
and working together to create a whole that is stronger than the sum of its parts. 
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Figure 1.1: Cortical bone. On the left of (A), a segment of a cross-section of human metacarpal 
cortical bone, surround the marrow cavity on the right of (A). In (B), a 3D volume render of a 
µCT cross-section of the same bone. In (C), a render of a segment of the neurovascular canal 
network. 
 
 
 
Figure 1.2: Trabecular bone. A 3D volume render of trabecular bone from the proximal radius 
of a rat 
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1.3 Bone growth and repair 
1.3.1 Growth 
Both trabecular and cortical bone undergo similar types of adaptation and renewal 
throughout life; this thesis will focus primarily on the aspects of bone growth and development 
that relate to cortical bone. The processes through which bone growth and development occur 
can be grouped into three main categories: longitudinal growth, modeling and remodelling (Frost 
1987). The longitudinal growth of bone is simply the addition of new primary trabeculae and 
cortical length to a bone over time.  
1.3.2 Modeling 
Modeling changes the geometry of the bone, including its shape and size, and takes place 
predominantly during the initial growth of the bone. As a result, bone formed during modeling is 
called primary bone. Primary bone is laid down quickly, encompassing neurovascular canals in 
the bone and forming primary osteons (Cooper et al. 2004). Primary bone can be laid down 
either as woven bone, with irregularly oriented collagen fibres, or as lamellar bone, in concentric 
layers forming circumferential rings in the diaphysis (Currey 2002).  
1.3.3 Remodelling 
Over an animal’s lifespan, this initially formed bone can be removed and replaced 
through remodelling. This process, which is dominant in larger terrestrial vertebrates, plays 
either only a minor role in bone upkeep or is absent in smaller animals such as mice and rats. 
Remodelling proceeds through the coordinated action of collections of bone cells working 
together as a Basic Multicellular Unit (BMU). Initiation of a BMU occurs with osteoclasts 
forming a cutting cone to remove existing bone, forming a resorption space, which is then filled 
in with osteoid, and mineralized by osteoblasts in a closing cone. A new canal is formed around 
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the neurovascular support for the cells, surrounded by concentric rings of new bone called 
lamellae (Robling et al. 2006). See figure 3 for details. The result of such remodelling is the 
continual creation of new vascular canals in the tissue. 
 
 
Figure 1.3: The basic structure of a BMU, with the osteoclast cutting cone shown at ‘A’, the 
resorption space shown at ‘B’, the osteoblast closing cone at ‘C’, and the resulting lamellar bone 
surrounding a Haversian canal at ‘D’.  
 
 
 These canals and the surrounding lamellae are known as Haversian systems or secondary 
osteons (Frost 1963). This process of remodelling has a significant impact of the strength of bone 
and its adaptation (Ammann and Rizzoli 2003). While trabecular bone orientation has long been 
used to infer loading environments (Koch 1917; Ryan and Shaw 2012), research investigating 
the relationships between canal structure and loading has been a more recent development (Britz 
et al. 2012b; de Margerie 2002). The orientation of the canals within both primary and secondary 
bone responds to the mechanical loading environment during their formation, similar to how the 
trabecular bone mesh responds to those same forces. Therefore, primary canals are likely to 
reflect conditions during growth while secondary canals and BMUs reflect loading conditions 
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over the course of the remodelling processes. Specifically, BMU orientation has been shown to 
align with the predominant stress orientation experienced by a bone (Hert et al. 1994; Petrtyl et 
al. 1996), indicating that the osteoclasts in the BMUs are sensing a stress or strain related signal.  
These signals are produced by osteocytes embedded in the bone, which sense mechanical 
stimuli and fluid flow in the lacunar-canalicular network (LCN) (Weinbaum et al. 1994) and 
translate them by mechanotransduction into electrochemical signals which can be acted on by 
neighbouring cells including osteoclasts and osteoblasts (Duncan and Turner 1995). Burger et al. 
(2003), showed that in the absence of fluid shear stress osteocytes underwent apoptosis and 
hypothesized that these apoptotic osteocytes attracted nearby osteoclasts. This would direct the 
progression of the cutting cone of BMUs locally, while the general course of their travel through 
the bone would be directed by changes in LCN interstitial fluid pressure aligned with the primary 
orientation of stress on the bone. Remodelling is at least partially initiated by microdamage 
caused by mechanical fatigue loading (Burr et al. 1985), where microcracks produced by cyclic 
loading are diverted into the lamellar structure of osteons. Martin proposed that all remodelling 
in normal tissue was induced by such microdamage (Martin 2002) and that BMUs can be 
initiated by this and steered towards the resultant microcracks, which have caused the death of 
nearby osteocytes (Martin 2007). The effect of this would be to remodel the bone containing the 
microcrack and repair the damage.  
The importance of the remodelling process can be easily noted as osteoporosis may result 
from a deficiency in the mechanotransduction system, whereby the bone would lose its ability to 
respond to loading (Santos et al. 2009; Seeman 2004). An imbalance in the remodelling process, 
an increase in osteoclastic resorption activity or a decrease in the formation of new bone by 
osteoblasts, can lead to decreased bone mass and density, and ultimately osteoporosis (Eriksen 
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2010). The ability to study the development of cortical porosity directly is therefore key to 
elucidating the nature of remodelling, and in particular the ability to longitudinally image in vivo 
and track the development and progression of BMUs in bone has the potential to answer many 
questions related to remodelling processes. 
1.4 Cortical bone imaging 
 Imaging cortical bone has traditionally been done using dry bone histological methods 
(Frost 1958), which while providing a wealth of knowledge are fundamentally limited as they 
cannot yield a full understanding of the three-dimensional (3D) nature of the bone 
microstructure. In response to this, serial sectioning histological techniques were developed 
which provide some three dimensional information (Dehoff 1983; Odgaard et al. 1990; Parfitt et 
al. 1987); however, such methods can be tedious and require destruction of the specimens under 
study. As a result such methods have largely been superseded by the use of micro-computed 
tomography (µCT). µCT was first used for the 3D imaging of bone microstructure in 1989 
(Feldkamp et al. 1989) and has several key advantages, including the ability to do quantitative 
3D analysis of the resulting digital image data of the microstructure, as well as preservation of 
the specimen. Many studies have since used desktop µCT to image the cortical network in 
humans (Basillais et al. 2007; Borah et al. 2010; Chen et al. 2010; Cooper et al. 2006; Cooper et 
al. 2007b; Cooper et al. 2003; Particelli et al. 2012; Wachter et al. 2001) and in rats (Britz et al. 
2010; Britz et al. 2012b; Jast and Jasiuk 2013). Desktop µCT has also been used to study 
trabecular dynamics in vivo in small animals such as mice and rats (Boyd et al. 2006a; Brouwers 
et al. 2007; Klinck et al. 2008; Matsumoto et al. 2011; Waarsing et al. 2004a). 
 µCT studies have also commonly used synchrotron x-ray sources as they can provide 
several advantages over desktop sources leading to greater quality images. These include higher 
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resolution and greater x-ray flux leading to the capacity for a monochromatic beam (Schneider et 
al. 2007). Synchrotron µCT (SRµCT) is the current gold standard for imaging bone 
microstructure and its advantages have been applied to both cortical bone and trabecular bone 
imaging (Matsumoto et al. 2011; Matsumoto et al. 2006; Matsumoto et al. 2007). SRµCT also 
provides the ability to use alternate contrast mechanisms such as phase contrast to illuminate 
bone features (Zhou and Brahme 2008).  
 The progression of in vivo µCT to higher resolution has been limited by the 
corresponding increase in radiation dose, where an increase in resolution by a factor of two while 
maintaining equivalent image quality increases the dose by a factor of sixteen (Ford et al. 2003). 
Desktop µCT is able to image trabecular bone microarchitecture at a safe level around 1 Gy and 
under in small animals such as mice or rats. However, at higher resolutions these doses become 
intolerable to the animals welfare, and effects can be seen in the bone tissue. As a result, in vivo 
imaging of cortical bone has as yet been unachieved. The primary goal of this thesis was to test 
the hypothesis that synchrotron phase contrast micro-CT is capable of resolving cortical bone 
porosity in vivo with a safe radiation dose. Specifically, the objective was the development of a 
protocol allowing the visualization of cortical neurovascular porosity in living rats at a dose 
comparable to that imparted by desktop imaging systems utilized for trabecular bone imaging. 
Since desktop µCT systems do not have the flexibility of techniques available that are achievable 
at a synchrotron, this objective was achieved through the use of phase contrast SRµCT at the 
Canadian Light Source synchrotron. The ability to perform longitudinal studies tracking cortical 
porosity progression will allow direct testing of causative hypotheses relating to remodelling and 
connected disease processes. 
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1.5 Organization of the thesis 
 Chapter 2 provides a review of the current state of µCT imaging, touching on both 
desktop and synchrotron sources, focusing specifically on in vivo bone imaging and imaging 
protocols as well as their specific limitations, primarily with regards to the radiation dose 
involved. This chapter will explore the quantitative parameters used to describe trabecular and 
cortical bone, the nature of radiation dose, the factors involved in dose, and examine the doses 
created by in vivo µCT protocols, the effects of these doses, and the methodology used to 
measure them.  
 Chapter 3 starts with a recap of cortical bone remodelling and an examination of x-ray 
propagation phase contrast imaging methods. It then describes the development of the protocol 
which is the focus of this thesis, the use of phase contrast SRµCT to visualize and quantify the 
cortical architecture of living small animals. Starting with ex vivo tissues, a series of SRµCT 
feasibility tests were performed, including phase distance determination and optimization. This 
experiment culminated with a terminal in vivo study which was able to visualize cortical porosity 
at a measured dose of 2.53 Gy. 
 Chapter 4 discusses the results, concludes the thesis, positions the main findings in 
relation to the current state of bone µCT research and discusses future research directions.  
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CHAPTER 2: THE STATE OF IN VIVO MICRO-COMPUTED TOMOGRAPHY 
IMAGING OF BONE 
 
2.1 Introduction to bone microstructure 
 Bone in the skeleton is divided into two major macroscopically distinguishable 
categories: 1) cortical or compact bone, the shell or outer layer of bone which forms the shaft of 
skeletal elements such as the femur or humerus, and 2) trabecular or spongy bone, which forms a 
honeycomb-like mesh of rod and plate shaped trabeculae. The standard method of quantitatively 
describing the bone microarchitecture is the use of morphometric indices and parameters 
(Dempster et al. 2013). Using micro computed tomography (µCT), these measurements can be 
made in three dimensions non-destructively (Borah et al. 2001; Cooper et al. 2003). There is a 
large body of research developing on in vivo longitudinal scans, focused mainly on trabecular 
bone in small animals (Waarsing et al. 2004a) and humans (Boutroy et al. 2005), but with 
increasing interest in cortical bone. An in vivo study of the complete picture of cortical bone 
porosity so far remains out of reach. 
2.1.1 Trabecular bone 
 The orientation of the trabecular network has long been known to align with major 
stresses; changes in the morphology of trabeculae have been linked to changes in disease state 
and have direct biomechanical consequences (Parfitt 1984). As a result, measuring and tracking 
these changes has direct relevance to questions in functional adaptation and health.  
 Trabecular bone quantification involves the direct measurement of parameters such as 
bone volume (BV), the full volume of the region segmented as bone, total volume (TV), and 
bone surface (BS), the surface of the region segmented as bone (Hildebrand et al. 1999), from 
which indices such as bone volume fraction (BV/TV), bone surface density (BS/TV), and 
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specific bone surface (BS/BV) can be calculated directly from two dimensional images, whether 
they are histological sections or µCT slices, or three dimensionally by counting voxels or using a 
volumetric marching cubes approach (Muller and Ruegsegger 1995).  
 From 3D µCT data parameters such as mean trabecular thickness (Tb.Th), mean 
trabecular separation (Tb.Sp) and mean trabecular number (Tb.N) can be directly calculated 
using sphere-fitting methods, which determine the thickness or separation based on the diameter 
of the largest sphere which is contained entirely in the trabeculae or spaces between them 
(Hildebrand and Ruegsegger 1997a). The mean trabecular number is the average number of 
trabeculae across a given unit length. It is calculated by taking the reciprocal of the addition of 
Tb.Sp and Tb.Th. One of the key advantages of direct 3D calculation of Tb.Th, Tb.Sp, and Tb.N, 
is that both mean values and the distributions of their variation can be obtained (Bouxsein et al. 
2010). Several techniques to quantify the orientation of trabeculae exist, through the 
measurement of the degree of anisotropy. When the orientation of trabeculae are preferentially 
biased in one direction over another, then we say that they are anisotropic, while if they are 
evenly distributed in direction, they are isotropic. The degree of anisotropy can be quantified 
based off calculations of mean intercept length, volume orientation, star volume distribution, or 
star length distribution (Odgaard 1997). The mean intercept length (MIL) is the most commonly 
applied method, and is explored in depth in Figure 1. Connectivity is an important measure of 
networks, and is traditionally defined as the minimum number of connections that can be broken 
before the structure is divided (Odgaard and Gundersen 1993). In trabecular studies, measures of 
connectivity are based on the Euler number of the sample, a topological property (Kabel et al. 
1999). Connectivity is typically measured as a connectivity density (Conn.D), the connectivity 
divided by the total volume of the region of interest. An index called the Structure Model Index 
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(SMI) is used to determine how the morphology of the trabeculae vary in general between 
idealized “rod-like” and “plate-like” types (Hildebrand and Ruegsegger 1997b). Trabecular bone 
has also been reported to be fractal in nature (Chappard et al. 2001) and as such a fractal 
dimension parameter can be calculated, representing an indication of the surface complexity of 
the bone and the complexity of branching trabeculae.  
 
Abbreviation Parameter Description Units 
TV Total volume Total volume of a selected region of interest 
(ROI) 
mm3 
BV Bone volume Volume of the ROI segmented as bone  mm3 
BS Bone surface Surface of the ROI segmented as bone mm2 
BV/TV Bone volume fraction Percentage of the ROI which is segmented as 
bone 
% 
BS/TV Bone surface density Ratio of the bone surface area to the total 
volume 
mm2/ mm3 
BS/BV Specific bone surface Ration of the bone surface area to the bone 
volume 
mm2/ mm3 
Tb.Th Trabecular thickness Mean thickness of trabeculae mm 
Tb.Sp Trabecular separation Mean distance between trabeculae mm 
Tb.N Trabecular number Mean number of trabeculae per unit length  mm-1 
DA Degree of anisotropy Measurement of trabecular structural anisotropy  
Conn.D Connectivity density Measurement of the degree of trabecular 
connectivity over the volume 
mm-3 
SMI Structure model index Measurement of the trabecular morphological 
structure 
 
D Fractal dimension Measurement of the trabecular surface 
complexity 
 
 
Table 2.1: Definition and description of 3D trabecular bone quantification parameters. 
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Figure 2.1: Illustration of the MIL method of DA calculation. The mean intercept length is 
found by passing a line through a 3D volume containing the region of interest, counting the 
number of intersections this line makes with part of the tissue (in this case bone) in the region of 
interest, and dividing this number by the length of the line. Differences in the MIL across 
different angles reflect the anisotropy in the bone. As seen in ‘A’, lines passing through the 
sample intercept the bone a different number of times depending on their orientation with respect 
to the anisotropy of the tissue. In 3D, many such lines are passed through the tissue (‘B’) to 
obtain MILs for a large number of angles to fully quantify the anisotropy over the whole volume. 
Next each line is drawn passing through the origin (‘C’), and the resulting polar plot is fitted to a 
3D ellipsoid with three main axes. The ellipsoid can be described as a tensor (3D matrix) with 
eigenvectors describing the strength of the anisotropy in the three major directions. From this 
tensor the DA can be calculated, by subtracting the division the maximum eigenvalue by the 
minimum eigenvalue from 1. The DA can then range from 0 to 1, where 0 is total isotropy and 1 
is total anisotropy. Figure adapted from the CT-analyser manual (Bruker 2012).  
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2.1.2 Cortical bone 
 Cortical or compact bone forms the outer shell of material, surrounding the marrow 
cavity in long bones. In most mammals, primary cortical bone grows in the lamellar pattern, 
where layers of bone are laid down circumferentially around the endosteal and periosteal 
borders, and around blood vessels and nerve fibers, which form canals running through the bone. 
After the bone is initially laid down, a process known as remodeling occurs, where osteoblasts 
and osteoclasts work together in Basic Multicellular Units (BMUs) to carve new, secondary, 
canals through the existing bone tissue. As a result of this process, the cortical bone is perforated 
by a network of connected neurovascular canals. Changes in the geometry and morphology of 
these canals through remodeling have been linked to aging processes (Cooper et al. 2007b) and 
health status changes including the development of increased bone fragility and osteoporosis 
(Seeman 2002). 
 Quantification of cortical bone morphology generally is done at two different levels, the 
gross geometry of the bone and the morphology of the canal network. Gross measurements 
include total cross-sectional area (Tt.Ar), marrow area (Ma.Ar), cortical bone area (Ct.Ar), the 
periosteal (Ps.Pm) and endosteal (Ec.Pm) perimeters, and cortical thickness (Ct.Th). 
Characterization of the geometry is often done by application of beam theory, calculating cross-
sectional second moments of inertia (Imax, Imin, Ix, Iy), and the polar second moment (J) for the 
bone. These moments can be related to bending strength and other mechanical properties of bone 
(Lieberman et al. 2004). Quantification of the canal network in three dimensions requires the use 
of µCT at a high resolution, typically with voxels of 10 microns or smaller (Basillais et al. 2007; 
Cooper et al. 2003), while quantification of the gross geometric parameters is possible at lower 
resolution, and can be done in vivo with current trabecular µCT protocols. Parameters including 
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tissue volume (TV), canal volume (Ca.V), canal surface (Ca.S) can be directly measured in three 
dimensions. Cortical porosity (Ca.V/TV) represents the relative volume of the canals within the 
tissue, the inverse of the trabecular bone volume fraction. Canal diameter (Ca.Dm) and canal 
separation (Ca.Sp) can be calculated based off the methods used for their trabecular analogues. 
Canal connectivity (Ca.ConnD) and canal length (Ca.Le) can be measured by using a 
skeletonization approach (Cooper et al. 2003) which measures the number of canal intersections, 
or nodes, and the distance between them. By measuring the angle of each skeletonized canal 
segment from the horizontal axis of the bone, canal orientation (Ca.Or) can be obtained (Britz et 
al. 2012b). The application of the structure model index (SMI) is relatively straightforward, as 
the idealized shape of a canal is similar to the ideal “rod-like” type in the SMI calculation. Basic 
Multicellular Units (BMUs) and associated resorption spaces within cortical bone can also be 
quantified with µCT using parameters including resorption space density and BMU range 
(Cooper et al. 2006).  
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Abbreviation Parameter Description Units 
Tt.Ar Total cross sectional area Total cross sectional area of the ROI mm2 
Ct.Ar Cortical area Area of the ROI segmented as bone  mm2 
Ma.Ar Marrow area Area of the marrow cavity mm2 
Ct.Ar/Ma.Ar Cortical area fraction Percentage of the ROI which is segmented as 
bone 
% 
Ps.Pm Periosteal perimeter Periosteal perimeter mm 
Ec.Pm Endosteal perimeter Endosteal perimeter mm 
Ct.Th Cortical thickness Mean thickness of the cortex mm 
I Area moment of inertia Measurement of resistance to bending, which 
varies in different directions, often indicated in 
subscript (Ix, Iy, Iap, Iml, Imax, Imin) 
mm4 
J Polar moment of inertia Measurement of resistance to torsion mm4 
    
    
TV Tissue volume Volume segmented as bone mm3 
Ca.V Canal volume Volume of the pores inside the bone  mm3 
Ca.S Canal surface Surface area of the pores inside the bone mm2 
Ca.V/TV Cortical porosity Percentage of the tissue volume that is canal % 
Ca.D Canal diameter Mean canal diameter mm 
Ca.Sp Canal separation Mean distance between canals mm 
Ca.Conn.D Canal connectivity 
density 
Measurement of the canal connectivity over the 
tissue volume 
mm-3 
Ca.Le Canal length Mean canal length mm 
Ca.Or Canal orientation Orientation of the canal away from the 
horizontal axis of the bone 
° 
SMI Structure model index Measurement of the canal shape  
 Resorption space density Density of resorption spaces in cortical bone spaces/m
m3 
 BMU range Mean length of BMUs mm 
 
Table 2.2: Definition and description of 3D cortical bone gross geometrical and microstructural 
quantification parameters. 
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2.2. Micro computed tomography 
 Micro computed tomography (µCT) was first used to image bone microstructure in 1989 
(Feldkamp et al. 1989). Two main µCT systems exist which can be applied to the study of bone 
tissues, synchrotron x-ray sources and polychromatic microfocus x-ray tubes in so called 
‘desktop’ systems which are often built and supplied by commercial vendors.  
2.2.1 Synchrotron µCT 
 Synchrotron µCT is performed using x-rays produced as bremsstrahlung, or breaking 
radiation, created by the passage of an electron beam traveling near the speed of light through 
incredibly strong electromagnets. This x-ray beam travels down a beamline and is collimated, 
and can then be filtered by a monochromator if desired, selecting out x-rays in a narrow energy 
bandwidth of less than a hundred eV (Kinney et al. 1998). The number of x-ray photons passing 
through a given area over a given time, or flux, produced by synchrotron sources is several 
orders of magnitude greater than that produced by desktop sources (Kinney et al. 1998), which 
allows for this monochromation while still producing enough flux for imaging. A technical 
limitation of polychromatic imaging is the spread of x-rays with different energies which are 
differentially absorbed by tissue. As a result, the lower energy x-rays in the beam are absorbed 
faster in the tissue, while the higher energy end of the beam penetrates more easily. As a result, 
tissue areas of increasing thickness result in an increase in the average energy of the beam 
exiting the sample. In CT, this results in so called “beam hardening” artifacts, where the linear 
attenuation coefficients are artificially low in the interior of the sample and vice versa. 
Monochromatic beams allow for the measurement of the bone mineral density based on the 
differential absorption of x-rays by the bone tissue and, as the beam is very close to a single 
energy, avoids beam hardening artifacts in the reconstruction (Peyrin et al. 1998). Synchrotron 
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sources offer higher resolutions than typical desktop x-ray sources, with submicron level 
imaging, or nanoCT, becoming more common at these institutions (Andrews et al. 2010; Peyrin 
2009; Schneider et al. 2007; Voide et al. 2009). Imaging at synchrotron sources can also take 
advantage of additional contrast mechanisms based on interactions between x-rays and matter 
other than absorption. Refractive index based imaging techniques including phase contrast 
(discussed further in Chapter 3) can provide improved visualization of smaller or more obscure 
targets. The disadvantages of synchrotron µCT are the limited access time, increased cost, and 
higher difficulty of use compared to common commercial systems.  
2.2.2 Desktop µCT 
 Many commercial desktop µCT systems exist, using polychromatic microfocus x-ray 
tubes to image at high resolutions. These systems produce a cone shaped beam, which allows for 
geometric magnification but also increases blurring. The resolution of these systems is typically 
limited by the spot size of the x-ray tube, and their ability to image is limited by the current and 
energy of the tube. These two characteristics are intrinsically linked, as a smaller spot size limits 
the amount of current which can be applied across it without damaging the tube. 
2.2.3 Dose 
 Radiation is the propagation of energy through a material. X-rays are a form of 
electromagnetic waves with moderately high quanta energy. These quanta or wave packets are 
called photons, and each carries a discrete amount of energy. As a beam of x-rays pass through 
material, the photons in the beam interact with the surrounding object, and may collide with its 
atoms. The atoms in the material absorb the energy from the photons, and this process ionizes 
electrons from the atoms. This ionization can disrupt molecular bonds and is therefore harmful to 
living tissues. The probability of an absorption happening is related to the atomic number (Z) of 
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a potential absorbing atom, and inversely proportional to the energy of the incident photon. What 
this means is that higher Z elements in tissue tend to absorb more x-rays than lower Z elements, 
and higher energy photons are absorbed less. Radiation dose is simply a measure of how much 
energy is deposited by the x-ray beam into the material, or in this case tissue. As the x-rays pass 
through the material, the beam is attenuated, and as a consequence the radiation exposure at the 
x-ray entrance point is higher than at the exit. In computed tomography this means that there is 
an uneven distribution of radiation in the object, with the center receiving the least amount of 
dose, and the surface being the highest. In small objects or samples, this effect is overshadowed 
by the difference absorption characteristics of different materials. For example, the bone in a 
limb will absorb more than the marrow it contains. 
 The absorbed dose is the energy deposited per unit mass of tissue, and is measured as 
joules per kilogram or grays (Gy). Closely related to the absorbed dose is the kerma, a term 
describing the kinetic energy transferred to charged ionizing particles from the x-ray beam per 
unit mass of the material. The key difference between absorbed dose and kerma is that the 
energy in the kerma is not necessarily contained in the location of the interaction between the 
beam and the tissue but may end up absorbed in a different place in the tissue. With regards to 
diagnostic x-rays, the absorbed dose and the kerma can be treated as equivalent(Bushberg 2002). 
Different materials will absorb different amounts of radiation, and therefore will have material 
specific kerma, and we may talk of air kerma, for absorption in air, or tissue kerma for 
absorption in soft tissue. Different sources of radiation can deposit differently into biological 
tissues, so a radiation weighting or quality factor, defined by the International Commission on 
Radiological Protection (ICRP), is used to convert the absorbed dose into a so called equivalent 
dose, measured with units of sieverts (Sv). The weighting factor for x-rays is 1, so in this case 
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the equivalent dose and the absorbed dose will have the same value. A further quantity called the 
effective dose can be calculated for the radiation effects on isolated parts of the body, and is 
commonly in use for dosimetry in human studies using computed tomography and other 
radiometric methods. For reference, the tissue weighting factor for some selected tissue types are 
0.01 for bone surfaces, 0.12 for red bone marrow, 0.01 for skin, 0.12 for the lungs, 0.12 for the 
colon, 0.08 for the gonads, and 0.04 for the thyroid (United Nations. Scientific Committee on the 
Effects of Atomic Radiation. 2010). The mean effective dose for some selected human CT 
examinations in first world heath care systems are 2.4 mSv for head, 7.8 mSv for thorax, 12.4 
mSv for abdomen, 5.0 mSv for spine, and 9.4 mSv for the pelvis (United Nations. Scientific 
Committee on the Effects of Atomic Radiation. 2010). The dose for a single HRpqCT scan of the 
forearm is under 3 µSv (Boyd 2008). As a comparison, radiation from cosmic rays during airline 
flights create a mean effective dose of 38.7 µSv for a 7.7 hour flight from Chicago, IL to 
London, GB (Freidberg et al. 1999).  
 The computed tomography dose index (CTDI) is a radiation exposure index reported by a 
commercial CT manufacturer based on the average dose imparted to a phantom with a given 
acquisition protocol. It can then be used in conjunction with the body mass of the subject to 
calculate an absorbed dose. The CTDI values calculated do not always accurately reflect the 
patient dose, (McCollough et al. 2011) especially given the differences between modern and 
older commercial systems(Boone 2007). 
2.2.4 Dosimetry 
 The two most common methods for measuring radiation dose in µCT imaging are ion 
chambers and thermoluminescent dosimeters (TLDs). Small ion chamber probes can be placed in 
the beam path to measure the air kerma during a scan, which can then be converted to the 
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absorbed dose (Shope et al. 1981). An ion chamber is a gas enclosed chamber with two 
electrodes, an anode and a cathode. A voltage potential applied across the electrodes creates an 
electric field in the gas. As x-rays pass through the chamber, they ionize particles in the gas, 
creating ion pairs of resulting positive ions and dissociated electrons. The electromagnetic field 
created in the chamber draws these particles to the anode and the cathode, creating an electric 
current which is proportional to the flux of the beam passing through. From this the dose can be 
calculated with reference to the ion chamber parameters. Ion chamber dosimetry is well 
established in the field, and is commonly used in µCT studies (Bayat et al. 2005; Brouwers et al. 
2007; Klinck et al. 2008). Ion chambers need to be specifically calibrated for the energy range of 
the x-ray source. The other common method is the use of thermoluminescent dosimeters. TLDs 
are small inorganic scintillator crystals, in which electrons are trapped in excited states. If the 
crystal is later heated, the electrons return to their ground state and emit light. Measuring the 
emission of this light is proportional to the absorbed dose. The most common material used is 
lithium fluoride (LiF), because it exhibits very little release of the trapped electrons at room 
temperature. Also, the effective atomic number of the LiF crystal is close to that of soft tissue, 
meaning the absorbed dose in the dosimeter is closely proportional to a tissue dose over the 
energy range of imaging x-rays (Bushberg 2002). TLDs are useful as they are very small, and 
can be placed at specific locations on an animal, to measure dose in that specific target area. 
TLD dosimeters can also be implanted into animals to measure the deep tissue dose more 
directly and accurately (Figueroa et al. 2008). TLDs can either be sent offsite for measurement or 
used with thermoluminescent reader detectors and reused after an annealing cycle. Both ion 
chambers and TLDs are sensitive enough for use as dosimetry methods in small animal µCT 
(Bos 2001; Yu and Luxton 1999). OSL dosimetry is similar to TLD dosimetry, except the 
21  
crystals in use are read by subjecting them to selected frequencies of light instead of heat 
(Yukihara and McKeever 2008). A common crystal type is aluminum oxide, Al2O3:C (Yukihara 
et al. 2008). 
2.2.5 Scan parameters impacting dose 
 The development of current µCT systems has been driven by a need for higher resolution 
and higher signal to noise (SNR) to accurately characterize microscopic features in bone and 
other hard and soft tissues. As the requirements for particular studies tend to vary immensely, 
µCT systems have been built with an ever increasing list of customizable scanning parameters, 
including the resolution/voxel size, rotation step, exposure time, and frame averaging. They also 
offer the ability to change the x-ray spectrum generated by changing the voltage across the tube 
in a desktop scanner or directly manipulating the energy of the beam emitted by a 
monochromator at a synchrotron, in combination with the use of thin metal foils for filtration of 
low energy x-rays(Boone et al. 2004). Changes in any or all of these parameters will affect the 
radiation dose absorbed in the animal, and they can be placed into three main categories: factors 
affecting the length of the radiation exposure, factors affecting the energy spectrum of the x-ray 
beam, and factors affecting the number of x-ray photons passing through a unit mass of material.  
 The tradeoff between image contrast and dose is clear. Image quality is improved by 
increased statistical collection of data, which increases the time spent by an animal in the beam, 
whether it is the number of rotations, the number of frames averaged, or the exposure time per 
frame. The ability to overcome noise is dependent on passing a sufficient number of photons 
through the tissue to provide contrast, which is equal to a requirement for spending enough time 
in the beam. Generally, for an increase of the signal or contrast to noise ratio by a factor of two 
will require an increase of the absorbed dose by a factor of four. At higher resolutions, passing 
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enough x-rays through smaller focal points in the material requires passing more x-rays through 
the whole material, and an improvement in resolution of a factor of 10 will increase the dose by a 
factor of 104 if the image quality is kept equivalent(Ford et al. 2003). Somewhat unintuitively, 
imaging with a higher kVp results in substantially lower doses. This is a result of lower 
absorption of higher energy x-rays in tissue. See figure 2 for details.  
 A Monte Carlo simulation by Boone et al(2004) showed that the use of higher energies 
lowered the mean dose significantly. The authors calculated that at 80 keV, a 20mm diameter 
animal would absorb a mean absorbed dose of 34.075 µGy per 106 photons/mm2 at the isocenter 
of the beam, while at 25 keV the dose was 89.563 µGy, more than 2.5x higher. Significant 
increases in dose were found for higher kVp as well. A reduction in dose can be achieved by 
shaping the x-ray spectrum to increase the mean energy of the beam. Using 0.5-2mm metal 
filters cuts out low energy emission peaks from elements used in the x-ray tube such as tungsten 
(Boone et al. 2004) and shifted the peak in the x-ray spectrum to a higher energy. This has two 
drawbacks, it lowers the flux of the system leading to a necessity for longer exposure time to 
achieve the same statistics, and imaging at higher energy results in lower image contrast. Since 
the reduction in dose is due to less absorption in the tissue, a concurrent effect is the reduction in 
attenuation contrast in the resulting images. A trade-off must be found here, between the 
lowering of contrast at high energy and the resulting need for an increase in exposure time.  
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Figure 2.2: The energy absorption coefficients for soft tissue (ICRU4 NIST standard) and solid 
bone (NIST) in cm2/g plotted against energy, showing the decrease in energy absorption, and 
therefore absorbed dose, with higher x-ray energy. (Data from NIST, http://www.nist.gov/) 
 
2.3 Small animal µCT in vivo  
 The ability to image trabecular bone in small animals requires a much higher resolution 
than imaging in humans, simply due to the size difference between the corresponding trabecular 
structures. A meta analysis of trabecular parameters found that Tb.Th in humans ranges from 
about 83-296 µm, in rats from 50-115 µm, and in mice from 22-69 µm (Barak et al. 2013). As a 
result, the options for small animal (typically rat or mouse) imaging are limited to x-ray based 
µCT imaging, while options for human trabecular analysis include micro magnetic resonance 
imaging (µMRI) with 137 µm voxels and high resolution peripheral quantitative CT (HRpqCT) 
with 82 µm voxels (Krug et al. 2008). These imaging systems are not able to fully measure 
trabecular parameters in 3D and so-called semi-derived algorithms are used (Buie et al. 2007). 
Beginning in the early 1990’s high resolution in vivo µCT imaging of small animal trabecular 
bone was pioneered using monochromatic synchrotron x-ray sources (Kinney et al. 1995; Lane et 
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al. 1998). These efforts ultimately lead to the development of commercial desktop in vivo µCT 
scanners using polychromatic micro-focus x-ray tubes (David et al. 2003; Waarsing et al. 2004a). 
In vivo scanning of laboratory animals allows for the design and application of longitudinal 
studies, which have more power to detect causal relationships and make the direct observation of 
development possible in a single animal. Using a single study population provides data that is 
internally consistent and reduces the number of animals needed for the study. Dynamic data 
across the lifespan of a single individual are able to track shifts in individual trabeculae using 3D 
registration techniques (Waarsing et al. 2004b). This allows for localization and quantification of 
bone formation and resorption across the trabecular network (Boyd et al. 2006b; Schulte et al. 
2011). As such, they increase the options available to researchers for experimental studies of 
bone. The main limitation of in vivo µCT scanning is the radiation dose imparted to the animal. 
In addition to this, any movement by the animal will cause artifacts in the reconstructed image, 
so the area of interest must be securely held in place. Animals must be imaged under anaesthetic, 
to prevent such movement, either through the use of injectables, such as pentobarbital sodium or 
a combination of ketamine and xylazine, or more commonly using gas anaesthetic, typically 
isoflurane. The amount of time an animal can be kept under anaesthetic is limited with injectable 
anaesthetic as it is increasingly difficult to titrate an appropriate dose because the injectable 
drugs are metabolized at different rates in each individual animal. Gas anaesthetic allows for the 
plane of anaesthetic to be specifically tailored to each individual animal throughout the scan.  
The absorbed dose is to an approximation inversely proportional to the fourth power of 
resolution, so that any increase in resolution will have a corresponding strong increase in dose. It 
is for this reason that in vivo studies of cortical porosity, requiring approximately double the 
resolution as studies of trabecular bone, have remained out of reach. In humans and rats, average 
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Ca.D of 173±45 µm and 36±12 µm respectively were reported by Jowsey (1966) based on 
histological examination of the femur. Cooper et al (2007a) reported a mean Ca.D of 68.0 µm in 
humans and noted that cortical parameters had a significant dependence on resolution, with 
analysis becoming less stable with voxels greater than 10µm. Matsumoto et al (2006) found 
mean Ca.D of 17.5 µm in the tibiae of rats and noted that the smallest canals were 1 voxel 
(5.83µm) across, indicating that higher resolutions might be necessary to capture the full cortical 
pore network. 
2.3.1 Synchrotron in vivo µCT 
 Kinney et al (1995) were the first to perform in vivo µCT using a synchrotron, at the 
Stanford Synchrotron Radiation Laboratory (SSRL) in the United States on the x-ray wiggler 
beamline 10-2. They used 25 keV x-rays from a single crystal silicon monochromator with a 
charge-coupled device (CCD) detector. This instrument is known as the X-ray tomographic 
microscope (XTM) (Kinney et al. 1992). Kinney et al. (1995) were able to keep imaging time at 
less than 30 minutes per rat and used shuttering to reduce the beam exposure to the animal. A 
lead shield was used to cover the body of the rats during the scan, reducing the body’s exposure 
to scattered radiation. Anaesthetized Sprague-Dawley rats received a quoted dose of no more 
than 90 rads (0.9 Gy) to a 2mm high target area in the proximal tibia. Half the group was 
ovariectomized after the scan and all were scanned again 5 weeks after the first imaging session 
with the same parameters. Measurements of BV/TV, Tb.Th, Tb.Sp, and Tb.N were made. The 
voxel size and rotation step used for imaging were not specified, and the method for the dose 
calculation was not described. Further studies were performed at SSRL by the same group (Lane 
et al. 1999; Lane et al. 2003; Lane et al. 1998) with 23 µm voxels; however, the radiation doses 
and rotation steps were not specified in these studies. Another experiment quotes a rotation step 
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of 1°, leading to 180 projections (Kinney et al. 1998), but does not specify the resolution used or 
the radiation dose. Despite the great potential put forward by these studies at SSRL, studies of 
dynamic changes in trabecular bone architecture using in vivo synchrotron µCT remained few 
and were slow to appear, likely due to the limited nature of beamtime and the inherently difficult 
nature of synchrotron imaging. Bayat et al. (2005) published a study on the C3H/HeJ and 
C57BL/6J strains of mice, imaging at the ID19 beamline at the European Synchrotron Radiation 
Facility (ESRF) in France. Using the wiggler beam they imaged with a so-called monochromatic 
energy between 20-24 keV, and a 0.5 mm aluminum filter. A pixel size of 10 µm was used along 
with rotation steps between 0.3° and 0.5°. Under these conditions they found a dose in the range 
of 2-20 Gy, depending on parameter choices (Bayat et al. 2005). They report higher image 
quality as the dose increases, and chose comparison points of 2.3, 7.5, and 14.5 Gy with no 
significant differences in mineralization between the 7.5 and 14.5 Gy dose levels. They also note 
no apparent damage to the mice. Coan et al (2010b) published a study using in vivo analyzer-
based imaging (ABI), hereafter referred to as diffraction enhanced imaging (DEI), of guinea 
pigs. Using the ID17 biomedical beamline at the ESRF, imaging at 52 keV with 47 µm pixels. 
DEI uses an additional, analyzer, crystal to enhance the image contrast through refraction of the 
x-ray beam at material or geometrical interfaces in the sample. They quote a skin entrance dose 
of 0.15 mGy per projection image. DEI-CT at a 0.24° rotation step through 360° would then 
produce approximately 225 mGy per scan. Matsumoto et al. (2011) published a short term study 
on bone dynamics in an unnamed strain of mice at the Experimental Animal Facility and 
Biomedical Imaging Center of the Super Photon ring-8 GeV (SPring-8) synchrotron in Japan. 
They used the bending magnet beamline 20B2, imaging in Hutch 3, imaging at 25 keV. Imaging 
was performed with 11.7 µm pixels and 0.2° rotation steps, leading to a quoted dose of 5.0 Gy 
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(Matsumoto et al. 2011). They note this level of radiation dose is high enough to inhibit cell 
proliferation and induce cell death in osteoblast cultures (Dare et al. 1997; Matsumura et al. 
1996) and reduce the ability of the bone to grow in the long term. Synchrotron radiation was also 
used by Choi et al. (2010) to perform in vivo projection based in-line phase contrast imaging on 
DBA/1J mice with collagen induced arthritis (CIA). The animals were exposed using a 
polychromatic beam produced at the 1B2/microprobe beamline at the Pohang Light Source 
(PLS) in Korea. The energy range of the beam was 7-14 keV which produced doses between 0.8 
and 3 Gy per image with a spatial resolution of 1.48 µm.  
 The advantages of synchrotron imaging are its high resolution and adaptability, high flux 
at a wide energy range, monochromaticity, and the potential for imaging using refractive index 
based contrast; however, synchrotron sources also tend to produce higher doses, beamtime is 
limited, set-up can be difficult and few synchrotrons have established in vivo imaging programs. 
In addition, the fixed nature of the source means that the animal must rotate in the beam, 
complicating the imaging process and requiring a more precise stage setup. A synchrotron source 
cannot match the ability for high throughput of a desktop x-ray tube source, though this 
throughput comes at the expense of lower contrast and resolution. 
2.3.2 Desktop in vivo µCT 
 Because of the limitations of synchrotron imaging, many teams were quick to develop 
desktop x-ray sources capable of high resolution imaging, centered around the ability to image 
an animal in vivo (Kohlbrenner et al. 2001; Paulus et al. 1999; Ruegsegger et al. 1999; Sasov 
2002; Sasov and Dewaele 2002). Although synchrotron sources are able to image at higher 
resolution, Peyrin et al. (1998) determined that 14 µm was sufficient to give a reasonably good 
quantification of the trabecular architecture, a resolution which is commonly achievable in 
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desktop systems. These systems are built around either stacked fan beam x-ray sources 
(Kohlbrenner et al. 2000) or cone beam tubes (Reimann et al. 1997). Much of this work was 
done either by or in collaboration with scientists from commercial enterprises, and in the early 
2000’s a number of studies used prototype commercial µCT scanners designed for in vivo 
imaging. David et al. (2003) used a prototype system built by ScanCo medical, a VivaCT 20. 
This system acts, as is typical with desktop in vivo systems, using a rotating gantry, where the x-
ray source and detector rotate around the object being scanned. This allows for straightforward 
continuous flow of gas anaesthetic during a scan, as well as a consistent static geometry of the 
animal in the scanner, reducing the chance of movement of extraneous body parts during the 
scan. The VivaCT 20 has anisotropic voxels of 20 x 20 x 26 µm, similar to the resolution used in 
in vivo synchrotron scanning. No radiation dose is quoted. Similarly, Waarsing et al. (2004a) 
published a study using a prototype SkyScan 1076 µCT scanner. This system operates with a 
rotating gantry, and has a 100 kV tube with a spot size of 5 µm. Projections were taken with 
voxels of 10 µm, which was then undersampled to 20 µm voxels in the reconstruction. Scans 
lasted 20 minutes and produced roughly 0.4 Gy, measured by “a dosimeter”. The tibia was 
scanned as it can be easily stretched back and isolated from the rest of the body, reducing 
radiation dose to the core of the animal.  
 Since the first pioneering studies, development in the µCT industry has proceeded 
rapidly, and scanning systems use rotating gantry cone beam micro-focus x-ray tubes and can 
achieve resolutions between 9-100 µm, performing scans in under 20 minutes. They provide 
filtration options for the beam, using thin metal foils of aluminum, copper, or other metals, and 
have a wide energy bandwidth (ranging from 20 to over 100 keV). The incredible amount of 
options available to the researcher, from the system level down to the parameter level, means 
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that predicting the dose imparted by a scan can be challenging, and achieving the requisite 
contrast at the required resolution may incur a dose that is not tolerable for the wellbeing of the 
animal.  
2.3.3 Effects of radiation dose on bone 
 Given the number of parameters that can affect the radiation dose in a given protocol, it is 
important to establish what level of dose can be tolerated. Side effects from overdose can have a 
direct influence on the skeletal system, and the level of dose a scan creates can cause different 
effects. Discrepant results have been found concerning the doses required before changes to the 
bone microarchitecture can be detected in rodents, and these effects have not yet been fully 
investigated. 
 The primary mechanism for cell death in irradiated tissue is DNA single and double-
strand breaks after ionization by the x-ray beam (Olive et al. 1990). This damage initiates DNA 
repair processes and can decrease cell proliferation (Iliakis et al. 2003). Studies in vitro have 
shown that radiation doses of 4 Gy and above inhibit osteoblast growth and proliferation (Dare et 
al. 1997; Dudziak et al. 2000; Gal et al. 2000), and while a 2.5 Gy dose has been shown to 
stimulate osteoclast activity (Scheven et al. 1985), a 2 Gy dose was shown to inhibit osteoclast 
activity (Willey et al. 2008). It is well accepted that proliferating cells are more sensitive to dose, 
and radiation damage to cells such as growth plate chondrocytes and red marrow bone cells may 
cause more obvious defects (Bisgard and Hunt 1936; Huang et al. 2009). Imaging away from the 
growth plate may therefore reduce the physiological impact of the radiation dose created in a 
scanned animal. While bone cells are sensitive to radiation, it is important to understand the 
response of the cells in the context of their tissue. In addition, it is important to differentiate the 
effects of a whole body dose from those resulting from irradiation of only a small part of a limb. 
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In humans a whole body dose of 250 mGy can lead to reduced lymphocyte counts (Bushberg 
2002); however, physiological responses to whole body doses will differ from partial limb 
irradiation.  
 A single dose of 5 Gy to the tibial metaphysis has been shown to impair bone 
regeneration in rats, with no effects found using a 2.5 Gy dose (Jacobsson et al. 1985). In rats, a 
study with 8 weekly scans at 939 mGy showed no significant difference in bone architectural 
parameters, or in the viability of the bone marrow cells (Brouwers et al. 2007). A study of rats 
with 7 monthly scans at 0.5 Gy showed significant decreases in trabecular structural parameters 
(Boyd et al. 2006a). The authors suggest this may be due to normal aging but it is consistent with 
effects resulting from radiation. In this study the dose was not measured but calculated by 
software provided by the manufacturer and it may be possible that this calculated dose is 
underestimating the true radiation dose to the animals. A study in C3H/HeJ (C3H), C57BL/6J 
(BL6), and BALB/cByJ (BAL) mice strains and Wistar rats used 4 or 5 scans for the OVX mice, 
4 for the control mice, and 6 scans for the rats. Doses of 712 mGy for the mice protocol and 503 
mGy for the rats were measured used an ion chamber probe (Klinck et al. 2008). They found no 
significant differences in the bone architecture of the rats but found small significant differences 
in the trabecular architecture and cortical geometry of the mice, which while detectable did not 
obscure the overall trend of the effects of the ovariectomy treatment used in the higher bone 
mass strains (BAL and C3H) with a less clear distinction in lower bone mass strains such as the 
BL6. Another study on C57Bl/6 (BL6) mice scanned 3 times separated by 2 week intervals using 
doses of 776 mGy, 434 mGy and 166 mGy. Significant changes were found in the 776 mGy 
scans but for the 434 mGy and 166 mGy scans no significant effects were found scans on the 
trabecular or cortical architecture as well as no hematological side effects (Laperre et al. 2011); 
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however, decreasing the dose from 776 to 434 mGy resulted in lowered image quality as 
expected.  
 An emerging trend in the literature is that the ability to tolerate dose varies not just 
between rats and mice but also between the various breeds of these animals. While some 
synchrotron studies image at high resolution with high doses that can be an order of magnitude 
larger than those used in desktop µCT systems (Bayat et al. 2005; Matsumoto et al. 2011), 
controls for radiation effects must be made. Using the non-irradiated contralateral limb along 
with a control group is essential. Other potential confounding factors include the age of the 
animals in the protocols, as young growing animals experiencing more rapid cell division will be 
more sensitive to radiation effects, which can more easily retard growth (Mitchell and Logan 
1998). 
 In order to image cortical bone porosity in vivo, doses on the same order as those used in 
trabecular in vivo imaging must be achieved, with an upper boundary set by those studies done at 
synchrotron sources. A dose of 5 Gy is the maximum used with the most common doses lying 
between 0.5 and 1.0 Gy. Achieving doses of this level while scanning at the higher resolution (at 
or below 10 µm pixels) required to capture the cortical network in vivo will be difficult. 
Advanced synchrotron imaging techniques which use contrast derived from refraction or 
interference may be required in order to longitudinally image cortical bone porosity in small 
animals without any radiation effects. 
32  
 
Publication Resolution Energy Dose Animal Target Number 
of Scans 
Age of 
animals 
Sex of 
animals 
(Kinney et 
al. 1995) 
N/A 25 keV 0.9 
Gy 
Sprague-
Dawley 
rats 
Proximal 
tibia 
1 6 
months 
Female 
(Kinney et 
al. 1998) 
N/A 25 keV N/A Sprague-
Dawley 
rats 
Proximal 
tibia 
3 6 
months 
N/A 
[46] 23 µm 25 keV N/A Sprague-
Dawley 
rats 
Proximal 
tibia 
5 6 
months 
Female 
(Lane et al. 
1999) 
23 µm 25 keV N/A Sprague-
Dawley 
rats 
Proximal 
tibia 
3 6 
months 
Female 
(Lane et al. 
2003) 
23 µm 25 keV N/A Sprague-
Dawley 
rats 
Proximal 
tibia 
3 6 
months 
Female 
(Bayat et al. 
2005) 
10 µm 20-24 
keV 
2-20 
Gy 
C3H/HeJ, 
C57BL/6J 
mice 
Knee 1 12 
weeks 
N/A 
(Coan et al. 
2010b) 
47 µm 52 keV 225 
Gy 
Dunkin 
Hartley 
guinea pigs 
Hip, 
knee 
1 6 
months 
Male 
(Matsumoto 
et al. 2011) 
11.7 µm 25 keV 5.0 
Gy 
Mice Proximal 
tibia 
2 13 
weeks 
Male 
(Choi et al. 
2010) 
1.48 µm 7-14 
keV 
0.8-
3.0 
Gy 
DBA/1J 
mice 
Forepaw 1 6 weeks N/A 
Table 2.3: Synchrotron protocols and their major features 
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Publication Resolution Energy Dose Animal Target Number 
of Scans 
Age of 
animals 
Sex of 
animals 
(David et al. 
2003) 
26 µm n/a n/a Wistar 
rats 
Proximal 
tibia 
4 4 month Female 
(Waarsing et 
al. 2004a) 
10 µm 100 kV 0.4 Gy Wistar 
rats 
Proximal 
tibia 
3 10 
month 
Female 
(Brouwers et 
al. 2007) 
15 µm 70 kV 0.939 
Gy 
Wistar 
rats 
Proximal 
tibia 
8 30 week Female 
(Boyd et al. 
2006a) 
15 µm 55 kV 0.5 Gy Wistar 
rats 
Proximal 
tibia 
7 8 month Female 
(Klinck et 
al. 2008) 
10 µm 55 kV 0.712 
Gy for 
mice, 
0.503 
Gy for 
rats 
C3H, 
BL6, 
BAL 
mice, 
Wistar 
rats 
Proximal 
tibia 
4 for 
control 
mice, 5 
for OVX 
mice, 6 
for rats 
12 week 
old 
mice, 8 
month 
old rats 
Female 
(Perilli et al. 
2010) 
8.7 µm 74 kV N/A Spragu
e–
Dawley 
rats 
Proximal 
tibia 
5 2 month Female 
(Laperre et 
al. 2011) 
9 µm, 
18 µm 
50 kV 0.776 
Gy, 
0.434 
Gy, 
0.166 
Gy 
BL6 
mice 
Proximal 
tibia 
3 4 week, 
10 
week, 
16 week 
Male 
(Lambers et 
al. 2012; 
Lambers et 
al. 2011) 
10.5 µm 55 kV 0.640 
Gy 
BL6 
mice 
Caudal 
vertebrae 
5 14 week Female 
(Campbell et 
al. 2011) 
12.5 µm 55 kV 0.338 
Gy 
Wistar 
rats 
Proximal 
tibia 
9 7-9 
months 
Female 
Table 2.4: Desktop µCT protocols and their major features 
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2.4 Conclusion 
 In vivo imaging opens new doors for researchers. Three dimensional registration of bone 
measurements allows for the detection and tracking of individual trabeculae in single animals 
(Boyd et al. 2006b; Nishiyama et al. 2010; Waarsing et al. 2004a). The potential for the use of 
these techniques is only beginning to be explored, and will have great impact in preclinical 
studies on pharmacological interventions and transgenic models. Longitudinal in vivo imaging 
depends on confidence in the measurements made. Given that radiation dose is known to affect 
the processes of bone development, it is important to fully quantify the effects of radiation to the 
bone and plan scan protocols to minimize its impact. The study of cortical bone architecture in 
vivo remains outside the grasp of conventional absorption methodology, as current imaging 
methods do not have the resolution required for complete quantification of the canal structure 
within cortical bone. The increase in resolution required for sufficient signal to noise puts the 
dose outside the safe and feasible imaging range; however, in vivo imaging of cortical porosity 
will be essential before the progression of remodeling can be fully elucidated. Advanced 
synchrotron methods dependent on refraction or phase contrast will be needed in order to 
overcome these limitations and bring the dose into a feasible regime.  
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CHAPTER 3: PHASE CONTRAST SYNCHROTRON µCT 
 
3.1 Introduction 
 Cortical bone is a dynamic tissue that undergoes adaptive and pathological changes 
throughout life. A full understanding of the nature of these changes is important to understand 
both healthy and abnormal changes in cortical bone, an integral part of the entire skeleton. This 
understanding however remains far from complete. Existing studies have been cross-sectional 
and ex vivo (Britz et al. 2010; Cooper et al. 2003; Jast and Jasiuk 2013; Particelli et al. 2012; 
Schneider et al. 2007) and do not represent the full subtlety of the slow processes involved in 
bone renewal. The process of remodeling is an essential component in disease pathways in 
osteoporosis and the structures involved in remodeling, basic multicellular units (BMUs), 
represent a biological signal which reflects the functional environment of a bone throughout life 
and the health of an individual. The study of cortical microstructure still largely depends on 
studies based on 2D histological techniques, limiting the appreciation of the intricate 3D 
network. Furthering the understanding of the complex interplay between bone formation and 
resorption through the remodeling process will depend on the ability to image cortical porosity in 
vivo. The details of BMU progression, including their rate of travel and change in 3D orientation 
and morphology over time, likely require longitudinal studies to unravel. While rats do not 
normally undergo remodeling, their size and the amount of previous work done on different 
strains makes them the best choice for cortical bone study. Remodeling can be easily induced 
using a variety of methods, including fatigue loading and calcium restriction models (Bentolila et 
al. 1998; Carter 1984; Kubo et al. 1999; Lieben et al. 2010). The ability to quantify BMU 
morphology and cortical porosity in vivo using µCT will require a new approach as the high 
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resolution necessary brings a corresponding high radiation dose which has been found to disrupt 
trabecular bone growth and remodeling processes (Klinck et al. 2008; Laperre et al. 2011).  
Phase contrast µCT has been shown to have potential for imaging cortical 
microarchitecture including porosity (Arhatari et al. 2011; Cooper et al. 2011b) and osteocyte 
lacunae (Carter et al. 2013; Langer et al. 2012) at even higher resolutions. Synchrotron Phase 
contrast has the potential to lower the radiation dose by enabling higher energy scanning than is 
typically possible in a desktop µCT system. The use of high energy synchrotron phase contrast at 
high resolution could bring the dose into the range used by conventional x-ray sources and allow 
longitudinal studies of cortical bone porosity.  
3.2 Phase contrast 
 The first commercial computed tomography system was developed in 1973 (Hounsfield), 
for which G. N. Hounsfield and A.M. Cormack shared the 1979 Nobel Prize in Physiology or 
Medicine. Traditional CT relies on differential x-ray absorption across materials or tissue types. 
A series of projection x-ray images are taken of an object rotated at angles from 0 to 180 
degrees, from which the 3D shape of the object can be reconstructed. Each pixel in the projection 
images represents a line integral of the x-ray energy absorption coefficients in the path through 
the object. The denser a material is to x-rays, the darker the resulting image will be. From the full 
series of projections, the integrals can be solved for the different absorption coefficients of the 
different materials in the object, creating a 2D map of the absorption coefficients that is parallel 
to the x-ray beam path through the object. In the reconstruction the image gray levels are 
inverted so that the background is dark and areas of higher absorption are bright. The energy 
from the x-rays absorbed in the tissue typically remains in the tissue, creating a radiation dose 
directly related to the contrast in the image.  
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 Phase contrast imaging is characterized by excellent image quality, enhanced contrast and 
increased tissue discrimination. Conventional medical imaging systems use polychromatic beams 
and rely almost entirely on x-ray absorption, ignoring information produced by scattering within 
the tissue. This phase shift, produced as photons pass through the tissue and scatter, is capable of 
generating significantly enhanced contrast (Zhou and Brahme 2008). The resulting phase 
contrast decreases less rapidly with increasing x-ray energy than absorption contrast, and is more 
tolerant to noise. Several methods of exploiting the phase shift exist and have been incorporated 
into synchrotron techniques, and use a monochromatic beam produced by a perfect crystal. Most 
of these methods, including diffraction enhanced imaging, and interferometry or diffraction 
grating phase contrast, use further crystal optics to refine the x-ray beam (see figure 3.1).  
 Diffraction enhanced imaging (DEI) uses a so called analyzer crystal between the object 
and the detector (see figure 3.1). As the x-ray beam passes through the object, it refracts across 
tissue or material interfaces in the sample, changing the angle of different parts of the beam. The 
analyzer crystal acts similar to a diffraction grating, and allows only a very narrow range of those 
angles through. By changing the angle the analyzer crystal is positioned at, it is possible to take 
images recording different refraction angles and to extract the phase and absorption components 
of the image (Chapman et al. 1997; Zhu et al. 2011). DEI has been used as a low dose method to 
enhance imaging capabilities in mammography (Hasnah et al. 2002; Pisano et al. 2000) and to 
visualize cartilage, which is typically transparent to x-rays (Izadifar et al. 2013; Mollenhauer et 
al. 2002). DEI has also been used to investigate trabecular and cortical bone, as a novel method 
for microarchitecture visualization (Coan et al. 2010b; Cooper et al. 2011a).  
 Interferometry is thought to be the most sensitive phase detection method as the 
refraction from the tissue is detected as interference fringes which are inversely related to the 
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deflection angle (David et al. 2002). When this deflection angle is large, as happens in interfaces 
between tissue types with structural boundaries with large differences in refractive indices, the 
fringes may become too narrow to be resolved (Zhou and Brahme 2008). These issues may be 
resolved by using phase gratings instead, creating a so-called Talbot interferometer (Pfeiffer et 
al. 2008). By placing a series of phase gratings along the beam path, one between the x-ray 
source and the sample, and two between the sample and the detector, deflections created in the 
sample can be detected (see figure 3.1). The first grating, called the source grating G0, is placed 
close to the x-ray source and converts the beam into a coherent virtual line source. Using this 
grating means that conventional polychromatic x-ray sources can be used, and commercial 
systems using this method of phase contrast are under development for human (Donath et al. 
2010) and small animal (Pauwels et al. 2012) imaging. The second grating, the phase grating G1, 
creates a phase modulation on the beam, and the third grating, the analyzer grating G2, is placed 
immediately in front of the detector and converts this into an intensity modulation, which 
appears as conventional x-ray contrast on the detector. 
 Propagation or in-line phase contrast is a refractive index based source of contrast that 
comes from interference of x-rays in the object (Snigirev et al. 1995). In a typical synchrotron 
parallel beam absorption based CT scan, the object is placed very close to the detector so as to 
minimize any geometrical distortion from the x-rays spreading out over time, whereas in a phase 
contrast set-up, the object is placed at a distance from the detector (see figure 3.1). In desktop 
µCT systems, this geometrical distortion is often exploited to produce magnification of voxels 
and increase the resolution of the system. In these cases the small distances involved and the 
polychromatic nature of the beam means that no significant phase contrast is typically in the 
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images, though optimization of the geometry of a system can produce phase effects (Sassov and 
Van Dyck 2000).  
 
 
Figure 3.1: Phase contrast imaging setups. In A, the setup for propagation phase contrast is 
shown, with the increased sample-detector distance. In B, the setup for DEI is shown, with the 
analyzer crystal. In C, the setup for grating based phase contrast is shown, with the source 
grating G0, the phase grating G1, and the analyzer grating G2.  
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Variations in thickness and x-ray refractive index due to changes in the composition and 
density of materials in the object being scanned influence the phase of the x-rays that are 
detected. This leads to excellent contrast in soft tissue compared to absorption imaging, where 
the different soft tissue types are often unable to be differentiated from each other and water due 
to their similar absorption coefficients (Momose et al. 1996). Phase contrast is used to visualize 
tissues such as cartilage (Coan et al. 2010a), organ tissue including breast, brain and lung (Lewis 
2004), and blood vessels without contrast agents (Momose et al. 2000). Phase contrast has also 
been used to examine fossilized hard tissues including bone and teeth (Betz et al. 2007; Lak et al. 
2008; Smith et al. 2007; Smith et al. 2010; Tafforeau et al. 2006). X-rays passing through an 
‘edge’ at the junction of two different materials are bent slightly, leading to changes in the x-ray 
wavefront that propagate over the distance between the object and the detector (see figure 3.2).  
 
 
Figure 3.2: Changes in the x-ray waveform through the use of propagation phase contrast. 
 
 
Because phase contrast depends on x-ray transmission through the target, its effectiveness 
at high x-ray energies is better than absorption contrast. This is a critical factor in the ability of 
41  
phase contrast protocols to lower radiation dose as imaging at higher energies reduces dose. The 
resulting effect is that the interfaces between materials of different x-ray absorption are 
highlighted by a fringe of bright and dark regions on the detector where the x-rays have been 
bent into distinct regions of high and low absorption on the detector. The width of these lines is 
dependent on the propagation distance between the object and the detector, and by varying this 
distance the width of these lines can be optimized to show a bright, easily distinguishable border, 
while preserving an accurate dimension of the highlighted structures. Imaging in cortical bone 
leads to a ‘halo’ around the periosteal and endosteal borders, as well as the edges of cortical 
canals and osteocyte lacunae (Britz et al. 2012a; Carter et al. 2013). Phase contrast at extremely 
high resolution is able to delineate osteons boundaries in cortical bone (Cooper et al. 2011b). The 
optimal phase distance to effectively delineate tissue boundaries depends on both the energy of 
the x-ray beam and the target resolution. Too large of a propagation distance will cause blur in 
the images as the phase shifts increase in magnitude, while too small of a distance restricts the 
divergence possible in the beam (Kotre and Birch 1999). 
 
Figure 3.3: The edge-enhancement effect can be seen in the graph on the right, where the bone 
tissue is on the left and the background is on the right. The phase peak has gray levels higher 
than the bone and lower than the background. The area in the graph is shown as the yellow line 
in the synchrotron µCT slice on the left. 
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 While phase contrast imaging can be done using a polychromatic source (Wilkins et al. 
1996) and commercial phase contrast systems are under development (Pauwels et al. 2012), 
these systems are not able to image at resolutions high enough for imaging cortical porosity or 
use gratings which, while producing excellent soft tissue contrast, are unsuitable for bone 
imaging as the bone produces too much of a phase shift and causes streaking artifacts (Tapfer et 
al. 2013). In-line phase contrast also has the advantage of requiring little additional set-up 
compared to absorption contrast, whereas grating based phase contrast requires the use of an 
interferometer in the beam. Other phase contrast techniques including diffraction enhanced 
imaging (DEI) may have potential for in vivo imaging (Coan et al. 2010b) but also require 
additional crystal devices and are subject to their other drawbacks as well. Human cortical 
porosity was able to be imaged ex vivo using DEI in humans at lower resolution than is possible 
through absorption contrast (Cooper et al. 2011a), but has not been explored in laboratory 
animals or in CT in vivo. 
 As mentioned in Chapter 2, the impact of parameters such as the energy spectrum of the 
x-ray beam, the amount and type of filtration used, the number of projection images acquired, the 
resolution, and the exposure time all have a great impact on the dose created in the animal being 
scanned, so I set out to optimize the phase contrast protocol to produce sufficient image quality 
to visualize cortical porosity while maintaining a feasible radiation dose. By controlling the 
number of projections, frame averaging, exposure time, and x-ray beam energy with around 10 
µm voxels, my goal was to lower the radiation dose to a feasible level for longitudinal imaging. 
By manipulating the phase propagation distance, I aimed to visualize cortical porosity at this 
resolution, and perform µCT to make these measurements at this resolution in vivo. 
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3.3 Materials and methods 
 Beamtime at the BioMedical Imaging and Therapy (BMIT) beamline at the Canadian 
Light Source (CLS) was obtained through peer review under proposals 17-4996 and 18-5466. 
Animal ethics approval was granted under protocol 2012-0112 by the University of 
Saskatchewan Animal Research Ethics Board of the University Committee on Animal Care and 
Supply and by the Canadian Light Source. 
3.3.1 Animals 
 Three male 8 week old Sprague-Dawley rats were used in this study. One animal was 
obtained ex vivo from a previous study (approved by the University of Saskatchewan Animal 
Research Ethics Board under protocol 2011-0124) where it had been used as a control animal for 
a study on the use of barium as an elemental tracker for new bone formation. The animals were 
purchased from Charles River and weighed 360 g and 381 g at the time they were scanned. The 
rats were housed in cages (16 × 27 × 42 cm), two animals per cage, at 20 °C with a light cycle of 
12 h with access to food and water ad libitum.  
3.3.2 Synchrotron ex vivo µCT 
 The BMIT 05B1-1 beamline is based off a 1.34T bending magnet x-ray source located 
within the 2.9 GeV storage ring at the CLS. The beam was prepared for imaging with a Bragg 
double crystal monochromator using Si (2, 2, 0) crystal reflections. The main imaging energy 
was 37 keV, located just above the k-edge of Barium, with comparison scans taken at 25 keV 
and 30 keV. This energy was used for easy applicability to other ongoing imaging projects. 37 
keV is near the top end of the ability for imaging at BMIT, as the spectrum of the bend magnet 
drops off quickly, especially when monochromated (see figure 3.4 for details). Two detector set-
ups were used: 1) a C4742-98-ERG Si CCD optical camera with a 1344 x 1024 array of 6.45 µm 
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x 6.45 µm pixels paired with an AA60 beam monitor P43 Gd2O2S:Tb 10µm thick scintillator, 
and 2) a C4742-56-12HR fiber optic window x-ray camera with a 2:1 FOP coupling of 10 µm 
fibers to a P43 Gd2O2S:Tb scintillator, resulting in a 4000 x 2624 array of 5.6 µm x 5.6 µm 
pixels (Hamamatsu, Hamamatsu City, Shizuoka Pref., Japan). Flat and dark field frames were 
collected before each scan to correct for noise in the detector and the x-ray beam. Pixel sizes in 
the projection images were 5 µm for the first camera without binning, 10 µm for the first detector 
with binning (2x2) and 11.8 µm for the second detector with binning (2x2). Specimens were 
scanned with exposure times ranging from 0.5-1.5s per frame, depending on the ring current, 
which decreases from a peak of 250 mA over time. Rotation steps of 0.24° and 0.5° were used to 
obtain 750 or 360 projection scans over 180°.  
 
 
Figure 3.4: The x-ray source brightness for the BMIT bending magnet beam line, from 0 to 100 
keV. 
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3.3.3 Ex vivo phase contrast setup and optimization 
 The front optical table at BMIT allows for a maximum distance from the sample to the 
detector of 1.2 m. Using an ex vivo forelimb tissue sample I captured a complete scan at 0.1m 
intervals to determine the optimal phase distance using both binning settings for the first camera 
and using the second camera. Once the phase distance is determined for a given set-up it can be 
directly translated from ex vivo to in vivo imaging without further configuration, so long as the 
energy and resolution remain the same.  
3.3.5 Synchrotron in vivo µCT 
 The Hamamatsu C4742-56-12HR fiber optic window x-ray camera was used at the 11.2 
µm resolution to scan two live Sprague-Dawley rats at 8 weeks of age. Slight divergence in the 
beam meant that the final spatial resolution was 11.8 µm. The direct fiber optic coupling in this 
detector system is up to 8-10 times more efficient than the lens based scintillator to CCD system 
used in the Hamamatsu C4742-98-ERG camera. The synchrotron x-ray beam was 
monochromated to 37.75 keV, a rotation step of 0.24 was used, leading to 750 projections. 
Aluminum filtration of 1.104 mm was used to eliminate any stray low energy harmonics. Due to 
lower ring current than normal at the CLS facility (a peak current of 145 mA compared to a 
normal peak of 250 mA), an exposure time of 1.2 s was used. A phase propagation distance of 
0.9 m was used.  
 A custom built stage developed in collaboration with BMIT staff members (see figure 
3.5) was used to fix the position of the forelimb in the path of the beam while holding the body 
of the animal steady and outside the imaging plane of the x-ray beam in order to reduce radiation 
exposure outside the target area. The stage also contains a place to attach a nose cone for gas 
anaesthetic. The animals were placed under isoflurane anaesthetic in an induction chamber under 
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the direction of the CLS veterinarian and their eyes were lubricated. They were then brought into 
the imaging hutch, where they were placed in the custom imaging stage and kept under 
anaesthesia using a nose cone until the end of the scan, at which point they were euthanized 
using an isoflurane overdose and exsanguinated. During the scan, the animals were monitored 
using CCTV video cameras, a pulse oximeter, a rectal thermometer, and their body temperature 
was maintained using a heat lamp. A fast shutter was used to stop the beam from irradiating the 
animals during the rotation of the stage between projections. During the scans, radiation 
exposure to the plane of the animals bodies was measured using luxel dosimeters (seen in figure 
3.5 on the left) in use at the CLS to measure personnel radiation exposure. Stray radiation can 
result from scatter of the x-ray beam. In a final protocol, the animals can be protected from this 
by lead aprons or shields. 
 
Figure 3.5: Rats positioned in the custom stage built at BMIT. On the left, a variant with the arm 
positioned in a tube in the beam. On the right, a variant with the arm held in a tube by a bridge. 
 
Detector Resolution Voltage Rotation step Filter Exposure time 
C4742-98-ERG 5 37 keV 0.5, 0.24 °  500-1500 ms 
C4742-98-ERG 10 25, 30, 37 keV 0.24 °  500-1500 ms 
C4742-56-12HR 12 37.763 keV 0.24 ° 1.104 mm Al 1200 ms 
Table 3.1: Synchrotron µCT imaging protocols used 
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3.3.4 Desktop µCT 
 Comparative images were acquired in SkyScan 1076 and SkyScan 1176 (Bruker 
SkyScan, Kontich BE) desktop µCT systems. These scanners are designed for in vivo preclinical 
imaging of small animals such as mice, rats, and rabbits, and use a rotating gantry setup where 
the x-ray tube and detector pair rotate around the specimen. It is worth noting that the SkyScan 
1176 is the newer model of the 1076 and possesses a higher power x-ray tube. The SkyScan 
1076 contains a 10 W sealed x-ray tube capable of 20-100 kV, while the 1176 contains a 25 W 
sealed microfocus X-ray tube capable of 20-90 kV. The detectors used in the two scanners are 
capable of imaging with 9 µm, 18 µm, or 35 µm pixels. The SkyScan 1076 has the capacity for 
imaging at 9 µm however the time frame required for imaging is quite high at over an hour.  
 Six different imaging protocols were used and described as follows and summarized in 
Table 3.1 below. These different protocols are an attempt to capture the variety of settings 
commonly used for in vivo µCT imaging of trabecular bone. The 18µm protocols are currently 
used by groups doing in vivo µCT at the University of Alberta and elsewhere. The 9 µm 
protocols were chosen to capture the range of doses that could be produced by these systems at 
their highest resolution. All protocols followed the alignment of the systems and the capture of 
full sets of flat and dark images. In the SkyScan 1076, scans were performed at 18 µm with the 
x-ray tube set to 70 kV and 140 µA, using a 1.0 mm Aluminum filter, a 0.5 ° rotation step 
producing 360 projections, each with three frame-averaging, and an exposure time of 1.180 s. At 
35 µm, scans were performed with the x-ray tube set to 70 kV and 140 µA, using a 0.5 mm 
Aluminum filter, a 0.5 ° rotation step producing 360 projections, each with three frame-
averaging, and an exposure time of 0.474 s. In the SkyScan 1176, at 18 µm, scans were 
performed with the x-ray tube set to 70 kV and 287 µA, using a 1.0 mm Aluminum filter, a 0.5 ° 
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rotation step producing 360 projections, each with three frame-averaging, and an exposure time 
of 0.350 s. At 9 µm, three different protocols were used to emphasize the ability of the system to 
produce drastically different radiation doses at the same resolution. In the ‘low dose’ protocol, 
the x-ray tube was set to 90 kV and 280 µA, using a 1.0 mm Aluminum filter, a 0.3 ° rotation 
step producing 600 projections, each with three frame-averaging, and an exposure time of 1.300 
s. In the ‘middle dose’ protocol, the x-ray tube was set to 70 kV and 287 µA, using a 0.2 mm 
Aluminum filter, a 0.3 ° rotation step producing 600 projections, each with three frame-
averaging, and an exposure time of 1.000 s. The high dose protocol used the x-ray tube set to 45 
kV and 550 µA, using no metal filter, a 0.3 ° rotation step producing 600 projections, each with 
three frame-averaging, and an exposure time of 1.300 s.  
 A high resolution ex vivo protocol was also performed using a SkyScan 1172 model with 
a 10 W x-ray tube capable of 20-100 kV with a <5 µm spot size, which is able to detect isotropic 
details down to 0.7µm. The specimen was scanned at 6.5 µm, with 45 kV, 222 µA, a 0.15 
rotation step producing 1200 projections, each with 4 frame averaging, and an exposure time of 
200 ms. 
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System Resoluti
on 
Voltage Amperage Rotation 
step 
Filter Exposure 
time 
Frame 
averages 
SkyScan 1076 35 µm 70 kV 140 µA 0.5 ° 0.5 mm 
Al 
474 ms 3 
SkyScan 1076 18 µm 70 kV 140 µA 0.5 ° 1.0 mm 
Al 
1180 ms 3 
SkyScan 1176 18 µm 70 kV 287 µA 0.5 °  1.0 mm 
Al 
350 ms 3 
SkyScan 1176 
‘low dose’ 
9 µm 90 kV 280 µA 0.3 ° 1.0 mm 
Al 
1300 ms 3 
SkyScan 1176 
‘medium dose’ 
9 µm 70 kV 287 µA 0.3 ° 0.2 mm 
Al 
1000 ms 3 
SkyScan 1176 
‘high dose’ 
9 µm 45 kV 550 µA 0.3 ° None 1300 ms 3 
SkyScan 1172 6.5 µm 45 kV 222 µA 0.15 ° 0.5 mm 
Al 
200 ms 4 
Table 3.2: Desktop µCT imaging protocols 
 
3.3.6 Software 
 Projections obtained from synchrotron µCT were flat and dark corrected using a custom 
ImageJ (ImageJ, NIH) macro, and reconstructed using NRecon (Bruker SkyScan, Kontich BE), 
commercial software developed for use with SkyScan desktop µCT systems. Projections 
obtained from the SkyScan 1076 and 1176 models were corrected and reconstructed using 
NRecon directly. Data visualization was done using Amira (Visualization Sciences Group, 
Burlington Ma, USA), CTVox ((Bruker SkyScan, Kontich BE), and ImageJ.  
3.3.7 Dosimetry 
 Lithium Fluoride (LiF) thermoluminescent dosimeters (TLDs) purchased from Mirion 
technologies (Mirion, Irvine Ca, USA) were used to measure the dose created by the synchrotron 
and desktop ex vivo protocols. Due to limited time and TLD availability either one or two LiF 
dosimeter devices were used for each scan. Each scan of a TLD chip dosimeter was performed 
using identical settings to the imaging protocols, with solely the TLD in the field of view. 
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Background radiation was corrected for using control crystals. The sensitivity of the TLD 
devices is 10 % as quoted from the commercial vender (Mirion). TLD chips have the advantage 
of small size and ease of use; however they are not always quickly available. As a result of time 
constraints, dosimetry for the synchrotron in vivo protocol was performed using a triad model 
Keithley 35050 ion chamber (Keithley Instruments, Inc., Cleveland, OH) calibrated for 
biomedical imaging. TLD dosimetry and this specific ion chamber model have been found to 
agree with an error rate of 2.5% (Figueroa et al. 2008). Luxel aluminum oxide (Al2O3) crystal 
OSL dosimeters were used in the in vivo phase to measure stray radiation impacted the animals 
bodies. Luxel dosimeter response was measured by Landauer (Landauer, Glenwood, IL). 
3.4 Results 
3.4.1 Resolution  
 Using the C4742-98-ERG camera I scanned at 5 µm and 10 µm to determine the 
resolution necessary to visualize the cortical porosity in the rat forelimb bones. 10 µm showed 
sufficient detail in the porosity and created at 10.0-10.8 Gy dose, and while using a 5 µm voxel 
size did improve the image quality, the resulting dose was much larger, at 25.6-35.1 Gy, than is 
tolerable for in vivo imaging in a small animal. See table 3.3 for details. 
 
51  
 
Figure 3.6: The difference between resolutions with 5 µm and 10 µm voxels using the C4742-
98-ERG camera. The phase propagation distance for the 5 µm image is 0.3 m and for the 10 µm 
image is 0.6 m. Doses of 10.0-10.8 Gy were measured for the 10 µm protocol and 25.6-35.1 Gy 
for the 5 µm protocol. 
 
3.4.2 Impact of number of projections 
 The number of projection images used to reconstruct the data set is a primary parameter 
in CT. Reducing the number used for reconstruction lowers the radiation dose but also reduces 
the resulting image quality due to a sparser sampling of image data. Higher numbers of 
projections tend to even out the image and reduce the noise levels within the data. I performed ex 
vivo µCT at BMIT and scanned the same sample at 360 projections and at 750 projections using 
the C4742-98-ERG camera to compare the resulting image quality, as shown in figure 3.6, with 
no frame averaging. Scanning with 360 projections resulted in images where the cortical porosity 
is visible but not able to be accurately segmented by a simple threshold.  
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Figure 3.7: The impact of the number of projections on image quality can be seen, with a scan of 
360 projections on the left compared to a scan of 750 projections on the right. These scans were 
performed with the C4742-98-ERG camera at 10 µm, and all other parameters were kept equal. 
Slice matches are not exact. Doses of 10.0-10.8 Gy were measured for this protocol. 
 
3.4.2 Propagation distance 
The propagation distance, between the object and the detector, is an important parameter for 
maximizing the image contrast obtained using in-line phase contrast µCT. Scanning at 0.1 m 
intervals I determined the optimal propagation distance for the C4742-98-ERG camera to be 0.6 
m at 10 µm and 0.3 m at 5 µm, and for the C4742-56-12HR camera to be 0.9 m at 11.8 µm.  
 
Figure 3.8: The optimal phase distance for the C4742-98-ERG camera at 10 µm was found to be 
0.6 m. Selected propagation distances of 0.1 m, 0.6 m, and 1.0 m are shown for comparison. 
Slice matches are not exact. Doses of 10.0-10.8 Gy were measured for this protocol. 
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Figure 3.9: The optimal phase distance for the C4742-98-ERG camera at 5 µm was found to be 
0.3 m. Selected propagation distances of 0.1 m, 0.6 m, and 0.6 m are shown for comparison. 
Slice matches are not exact. Doses of 25.6-35.1 Gy were measured for this protocol. 
 
 
Figure 3.10: The optimal phase distance for the C4742-56-12HR camera was found to be 0.9 m. 
Selected propagation distances of 0.25 m, and 0.9 m are shown for comparison. Slice matches 
are not exact. A dose of 2.53 Gy was measured for this protocol. 
 
3.4.3 Energy differences 
 Synchrotron scans at 25, 30, and 37 keV using the C4742-98-ERG camera at 10 µm with 
a phase distance of 0.6 m shows higher noise levels in the images taken at higher energy. The 
cortical porosity remains clearly visible and distinguishable from the phase contrast. The blurring 
in the lower energy images reflects that there are different optimal propagation distances at 
different x-ray energies, and in this case all three scans were taken using the optimal phase 
distance determined for 37 keV. Comparison images are shown in figure 3.11. 
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Figure 3.11: Differences in image quality using different x-ray energy in the tibia imaged using 
the C4742-98-ERG camera at 10 µm using a propagation distance of 0.6 m. Slice matches are 
not exact. Doses of 10.0-10.8 Gy were measured for this protocol. 
 
 
3.4.4 dosimetry 
Initial dosimetry for the ex vivo synchrotron µCT with the C4742-98-ERG camera at 10 
µm created a dose of 10.0-10.8 Gy measured with TLD dosimetry. This precipitated a move to 
the C4742-56-12HR fibre optic camera. Using the Keithley ion chamber I calculated a dose of 
3.2 Gy for the ex vivo preliminary tests and 2.5 Gy for the in vivo protocol. Using TLD 
dosimetry I obtained a dose of 1.2-1.5 Gy for the SkyScan 1176 µCT scanner at 18 µm, a dose of 
3.2-3.6 for the SkyScan 1076 scanner at 18 µm, a dose of 11.7-54.2 Gy for the SkyScan 1176 
scanner at 9 µm, depending on the protocol. Luxel dosimetry results indicated a minimal dose to 
the animal’s bodies of 0.45 mGy and 1.67 mGy. 
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System Protocol Energy Resolution Dosimetry 
method 
Dose 
C4742-98-ERG Ex vivo 37 keV 5 µm TLD 25.6-35.1 Gy 
C4742-98-ERG Ex vivo 37 keV 10 µm TLD 10.0-10.8 Gy 
C4742-98-ERG Ex vivo 30 keV 10 µm TLD 13.7 Gy 
C4742-98-ERG Ex vivo 25 keV 10 µm TLD 14.9 Gy 
C4742-56-12HR Ex vivo 37 keV 11.8 µm Ion chamber 3.15 Gy 
C4742-56-12HR In vivo 37 keV 11.8 µm Ion chamber 2.53 Gy 
SkyScan 1076 Ex vivo 70 kV 18 µm TLD 3.1-3.6 Gy 
SkyScan 1176 Ex vivo 70 kV 18 µm TLD 1.2-1.5 Gy 
SkyScan 1176 Ex vivo – high 
dose 
45 kV 9 µm TLD 48.1-54.2 Gy 
SkyScan 1176 Ex vivo – medium 
dose 
70 kV 9 µm TLD 18.6 Gy 
SkyScan 1176 Ex vivo – low dose 90 kV 9 µm TLD 11.7-18.2 Gy 
Table 3.3: Measured doses for the different protocols 
 
3.4.5 in vivo SR µCT 
The right forelimb of two 8 week old Sprague-Dawley rats were imaged at BMIT using the 
C4742-56-12HR camera at 11.8 µm. The results of these scans indicate that movement during 
the scan is an issue, from blood flow and insufficient limb restriction. That said, the imaging was 
a success and the cortical porosity can be visualized, especially the larger targets including BMU 
related activity. A horizontal and longitudinal slice are shown in figures 3.12 and 3.13, with a 
volume render in figure 3.14. 
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Figure 3.12: Single slice from the in vivo synchrotron µCT showing cortical porosity measured 
using the C4742-56-12HR camera at 11.8 µm with a 2.53 Gy dose. 
 
 
Figure 3.13: Longitudinal slice parallel to the long axis of the forelimb shows canals within the 
cortical bone, resliced in ImageJ from the in vivo scan using the C4742-56-12HR camera at 11.8 
µm. 
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Figure 3.14: Volume render of the cortical porosity in the forelimb µCT scan 
 
3.4.6 Comparison with desktop µCT 
Comparison scans were done in SkyScan 1076 and 1176 in vivo µCT systems at 35 µm, 18 µm, 
and 9 µm. Comparative slices from these systems are shown in figure 3.15, 16, and 17, though 
the matches are not exact. The resolving power of these scans was below that of the in vivo 
synchrotron scans, even the desktop scan with 9 µm voxels. A SkyScan 1172 high resolution 
µCT system, designed for ex vivo scanning, was also used to perform a scan with 6.5 µm voxels, 
with the results shown in figure 3.18. The image quality for resolving the cortical porosity is on a 
similar level to the synchrotron in vivo scans done at 11.8 µm. 
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Figure 3:15: Slice reconstructed from the in vivo desktop SkyScan 1076 at 35 µm. Matching 
slice to the Synchrotron in vivo, any deviation is from positioning differences during the scans. 
Dose was not measured but is presumed to be lower than other scans. 
 
 
Figure 3:16: Slice reconstructed from the in vivo desktop SkyScan 1176 at 18 µm with a 1.2-1.5 
Gy dose. Matching slice to the Synchrotron in vivo, any deviation is from positioning differences 
during the scans. 
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Figure 3:17: Slice reconstructed from the in vivo desktop SkyScan 1176 at 9 µm with an 11.7-
18.2 Gy dose. Matching slice to the Synchrotron in vivo, any deviation is from positioning 
differences during the scans. 
 
 
Figure 3.18: Slice reconstructed from the ex vivo desktop SkyScan 1172 at 6.5 µm. Matching 
slice to the Synchrotron in vivo, any deviation is from positioning differences during the scans. 
Dose was not measured but is presumed to be higher than other scans. 
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3.5 Discussion 
 Using the C4742-56-12HR camera at 11.8 µm, in vivo imaging of cortical porosity was 
achieved with a dose of 2.53 Gy, only slightly higher than doses used for in vivo analysis of 
trabecular bone. There are a number of future steps to be taken in order to lower the dose further. 
Technical limitations at the CLS and at BMIT meant that the camera readout time caused a delay 
in the imaging, and the ring current was lower than normal. 
 The number of projections is an important parameter in any approach to minimizing 
radiation dose to the animal. A change in the number of projections reflects a change in the x-ray 
exposure time to the animal, which is ultimately the most important parameter in the image 
quality. Any reduction in the time an animal spends in the beam, whether it is a reduction in 
exposure time, number of projections, or frame averaging, reduces the image quality, and the 
radiation dose. A reduction in one is often compensated for by an increase in the other 
parameters, and a balance must be found which best preserves the image quality. Signal to noise 
increases with the square root of the number of frames averaged (Webb 2003) so beyond 2-3 the 
parameter produces rapidly diminishing returns. Image quality at the centre of the reconstructed 
image is less reliant on larger numbers of projections, as the angular distance between 
projections is smaller towards the centre than at the outer edge of the image. New algorithms 
including iterative or compressed sensing approaches have potential to lower the number of 
projections required for imaging (Zhu et al. 2013) beyond what is possible with traditional 
filtered back projection reconstruction. In order to move beyond what is currently done with 
desktop in vivo µCT, parameters must be optimized before an increase in resolution can be 
attained. 
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 The other option for reducing dose in the case when higher resolution is needed is 
imaging at higher x-ray energy. In a desktop µCT this means increasing the voltage, which will 
reduce the amperage that can be used and require longer exposure times to maintain contrast 
levels. In addition, higher energy x-rays produce lower contrast between similar tissue types, and 
are less suitable for measurements of mineral content. As can be seen in figures 3.8-3.10, noise 
levels within the bone are quite high which may throw off local measurements of bone mineral 
density. An initial assessment of the literature indicated that 5 µm resolution would be necessary 
for visualization of the cortical porosity (Matsumoto et al. 2006; Matsumoto et al. 2007). After 
imaging at 5 µm and 10 µm with the C4742-98-ERG camera, and at 11.8 µm with the C4742-56-
12HR camera it appeared that the resolution provided by the 11.8 µm voxels still provided 
sufficient detail for cortical porosity visualization in the rats, likely due to the small spot size and 
precise collimation of the synchrotron beam along with the enhanced edge detection from the 
phase contrast. It is unlikely that this resolution would be sufficient to image cortical porosity in 
mice, as they have smaller cortical pores. See figure 3.12 as compared to figure 3.15-18: the 
desktop images are less noisy in the cortex, however, the level of porosity visible is lower except 
at the 6.5 µm resolution level. Dosimetry confirmed that imaging at 5 µm is likely unfeasible, 
with doses above 25 Gy. While I could likely have reduced that dose to the 10-15 Gy level by 
reducing the number of projections and the exposure time, the loss in image quality would 
produce images that are not suitable for data analysis. 
 The phase contrast makes a striking difference to the image quality, as shown in figures 
3.8-3.10. In the absorption images, very little of the porosity is visible while in the optimized 
phase distance images the cortical porosity is obvious and striking. Part of the reason for the lack 
of contrast in the absorption image is likely the high energy used for the imaging. Synchrotron 
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bone imaging is commonly done at 25 keV, allowing excellent images of cortical and trabecular 
bone and local differences in mineralization. Imaging at the higher energy of 37 keV the 
radiation dose is reduced by nearly 40 % while the cortical porosity remains visible as shown in 
figure 3.11. It is well worth noting that the radiation dose in the absorption and the phase images 
is the same, providing a simple mechanism for lowering the radiation dose while improving the 
image quality. While 37 keV is near the limit of the BMIT bending magnet (BM) beamline, the 
BMIT insertion device (ID) beamline, based on a superconducting wiggler, will have an order of 
magnitude higher brilliance than the BM beamline and be able to image at energies up to 100 
keV (see figure 3.19). This beamline is currently in commissioning status. The potential to image 
at 50 keV, just before the gadolinium k-edge (the fluorescent material in the scintillators I used), 
could further reduce the radiation dose by 46 % from the current imaging at 37 keV, bringing the 
current dose of 2.53 Gy down to a dose of 1.18 Gy, within the range of doses I measured for the 
desktop in vivo µCT protocols currently in use for trabecular bone imaging. 
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Figure 3.19: Brightness of the BMIT insertion device beamline compared to the BMIT bending 
magnet beamline. 
 
 The doses found for the desktop scanners were somewhat surprising and indicate what 
was previously noted: desktop “in vivo” scanners can create doses which are not tolerable to 
animals and which can easily affect the bone microarchitecture. Doses created by older scanners 
can be especially higher than expected. The doses created by the desktop protocol using the 
SkyScan 1076 at 18 µm were higher than the doses created by the synchrotron in vivo protocol at 
11.8 µm. These protocols are in common use. Users should be cautious with the settings they 
choose, especially on older desktop µCT systems, as the doses created by these systems are 
limited only by their choices. The number of projections, and the frame averaging should be 
chosen so as to minimize dose, as settings that are high may be producing image quality that is 
better than required for trabecular architecture quantification. The doses produced by the desktop 
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system for imaging at 9 µm were excessively high, and although this resolution is provided by 
the system, it may be inadvisable for use on live animals, as doses will likely be above 10 Gy. 
The three protocols I created for use with the 9 µm voxel level all provided roughly equivalent 
image quality, while producing drastically different doses, from 11.7 to 54.2 Gy. From the 
dosimetry data collected, the radiation dose produced by the in vivo synchrotron protocol of 2.53 
Gy falls within the range of desktop protocols at 18 µm, which produced doses from 1.2-3.6 Gy 
in the two desktop in vivo scanners.  
3.6 Conclusions 
Using the C4742-56-12HR camera at 11.8 µm, in vivo imaging of cortical porosity was 
achieved with a dose of 2.53 Gy. The use of propagation phase contrast enables a simple 
mechanism for dose reduction through high energy imaging. The dose created by the current 
synchrotron in vivo protocol is within the same order of magnitude as doses created by 
conventional desktop in vivo µCT, and future developments in technology will decrease that 
dose to levels within the range radiation doses created by common desktop µCT protocols. 
It remains to be seen whether radiation doses of this level have effects on cortical bone 
microstructure, as previous studies have only examined the effect of dose on trabecular bone 
parameters. As well, data on the effect of dose on bone growth remains limited, especially with 
regards to the effects of dose in relation to the age and sex of the study animals. It is likely that 
younger animals with more metabolically active bone tissue will demonstrate effects from 
radiation at lower doses, potentially encouraging the use of older animals. However, older 
animals with less active tissue will respond less to experimental treatments, requiring potentially 
longer study periods with less chance of success. With that said, longitudinal imaging of cortical 
bone porosity using synchrotron phase contrast creates doses which are on the cusp of feasibility, 
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depending on further study of the effects of these slightly higher doses on cortical bone 
remodeling.  
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CHAPTER FOUR: CONCLUSION  
 
 Relative to the base of knowledge on the mechanisms of growth and development in 
trabecular microarchitecture, comparatively little is known about the processes of renewal and 
repair ongoing within cortical bone. The goal of this thesis was the development and preliminary 
implementation of a method for longitudinal 3D imaging of cortical porosity. Much of the 
knowledge regarding remodelling activity in cortical bone has come from histological studies, 
and it is only the recent availability of high resolution 3D imaging tools that has enabled 
development in this field. The resolution limitations of non x-ray based technologies preclude 
their use for cortical bone imaging, and the radiation dose caused by conventional µCT has thus 
far prevented its use in this area.  
 
4.1 Overview 
 In chapter one the biological rationale for such a study was laid out and examined, and 
chapter two examined the current methodology in use for 3D bone imaging in vivo. It was found 
that current in vivo studies of bone using µCT are limited to trabecular bone analysis, as the 
radiation dose associated with high resolution cortical bone imaging is above the level shown to 
produce physiological effects on the scanned bone tissue. 
 Chapter three presented, to my knowledge, the first study to image the cortical bone canal 
network in living animals. Using high resolution propagation phase contrast synchrotron µCT at 
high energy, the cortical bone in the radius and ulna of a live rat was imaged using a C4742-56-
12HR camera at 11.8 µm, with a dose of 2.53 Gy. The methodology for optimizing and 
implementing a scan of this nature was laid out, with particular emphasis on the resolution 
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required and the implementation of the phase contrast method. This study opens new possibilities 
for longitudinal imaging of cortical porosity and BMU related remodelling processes. 
 
4.2 Future Directions  
 With this pilot study fully implemented, a large scale follow up study on the impacts and 
effects of this protocol is needed before experimental studies can progress. In particular, the 
effects of the radiation doses produced in the animal on cortical bone have not been quantified. 
Previous studies of radiation damage to bone have limited their focus to trabecular bone 
(Brouwers et al. 2007; Klinck et al. 2008; Laperre et al. 2011), as this has been the tissue under 
study. In this future study, it would be useful to scan animals at different dose levels, and 
examine the longitudinal effects of the imaging on the bone morphology. From such a study, the 
levels of safe imaging and the resulting image quality could be established as future longitudinal 
studies looking into structural growth processes in cortical bone need to be able to conclusively 
say that the effects seen are due to their experimental treatment and not to the effects of the 
radiation from the scans. Our group has planned a study examining the effects of two in vivo 
imaging sessions separated by two weeks. Groups of animals will be irradiated with doses of 1, 
2, or 3 Gy per scan, and then followed up with higher resolution ex vivo µCT. Future 
technological development at BMIT includes the opening of the ID beamline for user access. 
The energy range on this beamline is 20-100 keV, and will allow higher energy imaging in less 
time. The current dose can be cut almost in half by increasing the x-ray energy from 37 keV to 
near 50 keV. The limitation at this high energy will be the detector response, which is known to 
decrease at higher energy.  
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 One of the challenges for studies of cortical bone in small animals is the issue of 
remodelling. Rats do not normally undergo remodelling during life, but it can occur to mobilize 
calcium (Britz 2011) or as a response to damage in the bone (Noble et al. 2003). These 
mechanisms are exploited by a variety of different animal models to induce remodelling in rats 
or mice, by either increasing the loading regime, or increasing physiological demands for 
calcium. Different forms of exercise have been shown to induce cortical remodelling in rats 
(Notomi et al. 2000), and canal orientation changes depending on the loading regime present in 
the animals environment (Britz et al. 2012b). This model can be problematic as it is unclear 
whether it is the exercise itself which induces remodelling or whether the exercise is causing 
microdamage which is then causing the remodelling. This provides a confounding factor in 
studies on the relation of mechanical stimuli and remodelling as the BMU path will be altered by 
the creation of microcracks. In the second model, microcracks are induced deliberately through 
short periods of compressive loads placed on a limb, creating fatigue damage within the bone. 
This procedure has been shown to induce microcracks and remodelling; however, the exact 
mechanism for this process is as yet unknown (Macione et al. 2011; Mellon and Tanner 2012). 
The third model uses a methods to induce physiological mobilization of calcium, either a 
calcium restricted diet, an induced pregnancy followed by lactation, or a combination of the three 
(Medeiros et al. 2002). Remodeling in response to calcium restriction typically focuses on the 
endosteal surface, surrounding the medullary cavity, and is common as well in birds following 
egg laying (Bloom et al. 1941).  
 Using these different animal models, a variety of experimental studies can then be 
performed. Using longitudinal imaging of BMU related remodelling in cortical bone, the 
development of BMUs in bone can be tracked following fatigue loading, and following the 
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imaging protocol these bones can be histologically examined for signs of microcracks. By 
matching the histological slices and the in vivo µCT images, the progression of BMUs can be 
directly linked to the presence or absence of local microdamage, and the hypothesis that 
remodelling is steered towards microcracks can be tested. Specifically, the µCT imaging can 
locate the pre-existing BMUs and differentiate new growth and the direction of that growth after 
an experimental procedure, in this case the fatigue loading. There is no other technique that can 
visualize cortical porosity and BMUs in an in vivo animal model. 
 In addition to its use in laboratory animals such as mice and rats, questions involving 
larger animals can be examined as well. New Zealand white rabbits are a laboratory species 
which exhibit normal Haversian remodelling, and have potential for use in preclinical studies of 
drugs such as human parathyroid hormone (PTH), as well as estrogens, bisphosphonates, and 
other drugs which are known to affect bone structure and mass (Hirano et al. 1999). Longitudinal 
studies allow for direct testing of the effects of these drugs on cortical bone and the remodelling 
processes within, helping to elucidate the mechanisms by which these drugs act.  
The orientation of BMUs and osteons in long bones has been linked to loading and 
through load history to the animals locomotor behaviour (Britz et al. 2012b; de Margerie 2002; 
de Margerie et al. 2005). The use of in vivo imaging at specific time points during the 
development of an animal’s adult locomotor paradigm would allow for the measurement of 
direct change in the canal network and its relation to mechanical loading and behaviour. If such a 
link were established, it could allow researchers to look into the past and potentially determine 
new information about the locomotor behaviours of animals long extinct, or of human ancestors, 
adding to the knowledge provided by trabecular bone studies (Fajardo and Müller 2001; Fajardo 
et al. 2007; Griffin et al. 2010; Ryan and Shaw 2012; Sanchez et al. 2012).  
70  
 
4.3 Conclusion  
 This thesis has laid the ground work for an effective µCT protocol for imaging cortical 
bone porosity and BMU related remodeling in living animals using synchrotron propagation 
phase contrast. I have demonstrated that neurovascular canals within rat cortical bone can be 
visualized and quantified in 3D using phase contrast µCT, and while it is not possible to 
differentiate primary and secondary canals in vivo, the progression of canals will be traceable 
over time. The information gained from this study will inform a larger scale study on the effects 
of dose on remodeling, as well as experimental studies on remodeling in living animals. The 
ability to track the progression of individual BMUs over time cannot be underestimated for its 
importance in the creation of a fuller knowledge of the processes of renewal and repair in bone 
tissues. 
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SOP$1:$Propagation$Phase$Contrast$ $
$ Page%1%of%2%
University*Committee*on*Animal*Care*and*Supply*(UCACS)*
Standard*Operating*Procedure*(SOP)*$
 
SOP*#* Title$
1$ Propagation$phase$contrast$micro$computed$tomography$of$live$rats$
*
1. Purpose*
To$use$synchrotron$radiation$to$image$cortical$canals$in$the$peripheral$limb$bones$of$live$*$
rats$using$propagation$phase$contrast$x?ray$micro$computed$tomography.$
*
2. General*Information*
Using$phase$contrast$microCT$will$allow$for$the$safe$in$vivo$imaging$of$the$network$of$
cortical$canals$and$BMUs$which$are$important$in$the$study$of$remodelling$and$bone$growth$
and$development.$
$
3. Equipment/Materials*
PPE$
Isoflurane$anesthesia$system$(with$medical$grade$oxygen)$
Anesthetic$work$station$(with$induction$chamber$and$nose$pieces$for$rats)$
$
4. Procedure*
?$Animals$will$be$transported$from$the$Animal$Facility$to$the$CLS$following$SOP$Z101:$
Animal$Transport$and$Use$of$Animals$Outside$the$Animal$Facility$
?$Live$animal$imaging$will$take$place$with$the$facility$Animal$Welfare$Veterinarian$present.$
?$The$animal$will$be$transported$from$the$BMIT$animal$preparation$area$to$the$POE?2$hutch$
in$the$acrylic$induction$chamber$then$anesthetized$using$isoflurane$by$inhalation.$
?$The$animal$will$then$be$moved$to$the$CT$imaging$stage$and$restrained$for$safety$in$a$
custom$designed$holder$with$free$air$flow$where$it$is$immobilized$for$the$entire$10?30$
minute$scan.$$
?$Closed$circuit$cameras$will$be$trained$on$the$animal$to$monitor$breathing$and$signs$of$
distress.$A$digital$thermostat$will$maintain$ambient$room$temperature$
?$The$animal$will$be$scanned$under$continuous$flow$of$isoflurane/oxygen$
?$At$the$end$of$the$imaging$period$the$mouse$will$be$returned$to$the$acrylic$induction$
chamber$and$given$a$lethal$overdose$of$isoflurane$for$5$minutes$and$the$animal$will$be$
returned$to$the$BMIT$animal$preparation$area.$
$
5. Safety*
J*PPE*
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* lab$coat$or$gown,$gloves,$closed$toed$shoes$
?$Please$read$MSDS$and$ERP$regarding$proper$use$of$Isoflurane$
?$Be$familiar$with$proper$handling$of$medical$grade$oxygen$tanks$and$the$operation$of$?
anesthetic$machine$
?$Be$familiar$with$proper$animal$handling$techniques$
?$Contact$the$PI$or$the$University$Veterinarian$for$assistance$and$humanely$euthanize$if$
concerns$arise.$
$
6. Potential*Complications*and*Troubleshooting*
?$Beam$problems$(Short$term)$during$scans$at$the$CLS:$keep$animal$on$anesthesia$under$
monitoring$until$restoration$of$x?ray$flux.$
?$Beam$problems$(Long$term)$during$scans$at$the$CLS:$Humanely$euthanize$animal$and$
follow$post?scan$part$of$the$protocol$
?$Contact$the$PI$or$the$University$Veterinarian$for$assistance$and$humanely$euthanize$if$any$
welfare$concerns$arise.$
$
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